Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate

April 8, 2019 updated by: Boehringer Ingelheim

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate With Open Label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation: Prospective, Multi-centre, Parallel-group, Non-inferiority Trial (RE-LY Study)

The primary objective of this trial is to demonstrate the efficacy and safety of dabigatran etexilate in patients with non-valvular atrial fibrillation for the prevention of stroke and systemic embolism.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

18113

Phase

Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Argentina
- - Bahía Blanca, Argentina
    - 1160.26.0523 Boehringer Ingelheim Investigational Site
  - Capital Federal, Argentina
    - 1160.26.0524 Boehringer Ingelheim Investigational Site
  - Capital Federal, Argentina
    - 1160.26.0533 Boehringer Ingelheim Investigational Site
  - Cipolletti, Argentina
    - 1160.26.0526 Boehringer Ingelheim Investigational Site
  - Coronel Suárez, Argentina
    - 1160.26.0529 Boehringer Ingelheim Investigational Site
  - Córdoba, Argentina
    - 1160.26.0531 Boehringer Ingelheim Investigational Site
  - La Plata, Argentina
    - 1160.26.0530 Boehringer Ingelheim Investigational Site
  - Mar del Plata, Argentina
    - 1160.26.0527 Boehringer Ingelheim Investigational Site
  - Mar del Plata, Argentina
    - 1160.26.0532 Boehringer Ingelheim Investigational Site
  - Quilmes, Argentina
    - 1160.26.0525 Boehringer Ingelheim Investigational Site
  - Rosario, Argentina
    - 1160.26.0521 Boehringer Ingelheim Investigational Site
  - Salta, Argentina
    - 1160.26.0528 Boehringer Ingelheim Investigational Site
  - Santa Fe, Argentina
    - 1160.26.0522 Boehringer Ingelheim Investigational Site
Australia
- New South Wales
  - Coffs Harbour, New South Wales, Australia
    - 1160.26.0508 Boehringer Ingelheim Investigational Site
  - Gosford, New South Wales, Australia
    - 1160.26.0510 Boehringer Ingelheim Investigational Site
- Queensland
  - Herston, Queensland, Australia
    - 1160.26.0505 Boehringer Ingelheim Investigational Site
  - Milton, Queensland, Australia
    - 1160.26.0506 Boehringer Ingelheim Investigational Site
- South Australia
  - Ashford, South Australia, Australia
    - 1160.26.0509 Boehringer Ingelheim Investigational Site
- Tasmania
  - Launceston, Tasmania, Australia
    - 1160.26.0507 Boehringer Ingelheim Investigational Site
- Victoria
  - Box Hill, Victoria, Australia
    - 1160.26.0504 Boehringer Ingelheim Investigational Site
  - Geelong, Victoria, Australia
    - 1160.26.0501 Boehringer Ingelheim Investigational Site
  - Parkville, Victoria, Australia
    - 1160.26.0502 Boehringer Ingelheim Investigational Site
  - Prahran, Victoria, Australia
    - 1160.26.0503 Boehringer Ingelheim Investigational Site
Austria
- - Graz, Austria
    - 1160.26.0543 Boehringer Ingelheim Investigational Site
  - Linz, Austria
    - 1160.26.0549 Boehringer Ingelheim Investigational Site
  - Wels, Austria
    - 1160.26.0546 Boehringer Ingelheim Investigational Site
  - Wien, Austria
    - 1160.26.0541 Boehringer Ingelheim Investigational Site
  - Wien, Austria
    - 1160.26.0542 Boehringer Ingelheim Investigational Site
  - Wien, Austria
    - 1160.26.0544 Boehringer Ingelheim Investigational Site
  - Wien, Austria
    - 1160.26.0545 Boehringer Ingelheim Investigational Site
  - Wien, Austria
    - 1160.26.0547 Boehringer Ingelheim Investigational Site
  - Wien, Austria
    - 1160.26.0548 Boehringer Ingelheim Investigational Site
  - Wr. Neustadt, Austria
    - 1160.26.0550 Boehringer Ingelheim Investigational Site
Belgium
- - Aalst, Belgium
    - 1160.26.0564 Boehringer Ingelheim Investigational Site
  - Antwerpen, Belgium
    - 1160.26.0573 Boehringer Ingelheim Investigational Site
  - Antwerpen, Belgium
    - 1160.26.0575 Boehringer Ingelheim Investigational Site
  - Brasschaat, Belgium
    - 1160.26.0572 Boehringer Ingelheim Investigational Site
  - Brugge, Belgium
    - 1160.26.0577 Boehringer Ingelheim Investigational Site
  - Brussels, Belgium
    - 1160.26.0571 Boehringer Ingelheim Investigational Site
  - Bruxelles, Belgium
    - 1160.26.0581 Boehringer Ingelheim Investigational Site
  - Bruxelles, Belgium
    - 1160.26.0585 Boehringer Ingelheim Investigational Site
  - Bruxelles, Belgium
    - 1160.26.0586 Boehringer Ingelheim Investigational Site
  - Edegem, Belgium
    - 1160.26.0563 Boehringer Ingelheim Investigational Site
  - Genk, Belgium
    - 1160.26.0578 Boehringer Ingelheim Investigational Site
  - Genk, Belgium
    - 1160.26.0587 Boehringer Ingelheim Investigational Site
  - Gent, Belgium
    - 1160.26.0574 Boehringer Ingelheim Investigational Site
  - Gilly, Belgium
    - 1160.26.0588 Boehringer Ingelheim Investigational Site
  - Haine-St.-Paul, Belgium
    - 1160.26.0580 Boehringer Ingelheim Investigational Site
  - Hasselt, Belgium
    - 1160.26.0568 Boehringer Ingelheim Investigational Site
  - Kortrijk, Belgium
    - 1160.26.0569 Boehringer Ingelheim Investigational Site
  - Leuven, Belgium
    - 1160.26.0561 Boehringer Ingelheim Investigational Site
  - Liège, Belgium
    - 1160.26.0579 Boehringer Ingelheim Investigational Site
  - Liège, Belgium
    - 1160.26.0583 Boehringer Ingelheim Investigational Site
  - Mol, Belgium
    - 1160.26.0589 Boehringer Ingelheim Investigational Site
  - Oostende, Belgium
    - 1160.26.0567 Boehringer Ingelheim Investigational Site
  - Roeselare, Belgium
    - 1160.26.0570 Boehringer Ingelheim Investigational Site
  - Tienen, Belgium
    - 1160.26.0566 Boehringer Ingelheim Investigational Site
  - Turnhout, Belgium
    - 1160.26.0562 Boehringer Ingelheim Investigational Site
Brazil
- - Belo Horizonte, Brazil
    - 1160.26.550648 Boehringer Ingelheim Investigational Site
  - Blumenau, Brazil
    - 1160.26.550654 Boehringer Ingelheim Investigational Site
  - Campinas, Brazil
    - 1160.26.550644 Boehringer Ingelheim Investigational Site
  - Curitiba, Brazil
    - 1160.26.550650 Boehringer Ingelheim Investigational Site
  - Curitiba, Brazil
    - 1160.26.550651 Boehringer Ingelheim Investigational Site
  - Curitiba, Brazil
    - 1160.26.550653 Boehringer Ingelheim Investigational Site
  - Goiania, Brazil
    - 1160.26.550652 Boehringer Ingelheim Investigational Site
  - Marília, Brazil
    - 1160.26.550645 Boehringer Ingelheim Investigational Site
  - São José do Rio Preto, Brazil
    - 1160.26.550646 Boehringer Ingelheim Investigational Site
  - São José do Rio Preto, Brazil
    - 1160.26.550647 Boehringer Ingelheim Investigational Site
  - São Paulo, Brazil
    - 1160.26.550641 Boehringer Ingelheim Investigational Site
  - São Paulo, Brazil
    - 1160.26.550642 Boehringer Ingelheim Investigational Site
  - São Paulo, Brazil
    - 1160.26.550643 Boehringer Ingelheim Investigational Site
  - Uberaba, Brazil
    - 1160.26.550649 Boehringer Ingelheim Investigational Site
Bulgaria
- - Pleven, Bulgaria
    - 1160.26.0620 Boehringer Ingelheim Investigational Site
  - Sofia, Bulgaria
    - 1160.26.0611 Boehringer Ingelheim Investigational Site
  - Sofia, Bulgaria
    - 1160.26.0612 Boehringer Ingelheim Investigational Site
  - Sofia, Bulgaria
    - 1160.26.0613 Boehringer Ingelheim Investigational Site
  - Sofia, Bulgaria
    - 1160.26.0614 Boehringer Ingelheim Investigational Site
  - Sofia, Bulgaria
    - 1160.26.0615 Boehringer Ingelheim Investigational Site
  - Sofia, Bulgaria
    - 1160.26.0616 Boehringer Ingelheim Investigational Site
  - Sofia, Bulgaria
    - 1160.26.0617 Boehringer Ingelheim Investigational Site
  - Sofia, Bulgaria
    - 1160.26.0618 Boehringer Ingelheim Investigational Site
  - Sofia, Bulgaria
    - 1160.26.0622 Boehringer Ingelheim Investigational Site
  - Sofia, Bulgaria
    - 1160.26.0623 Boehringer Ingelheim Investigational Site
  - Sofia, Bulgaria
    - 1160.26.0624 Boehringer Ingelheim Investigational Site
  - Sofia, Bulgaria
    - 1160.26.0625 Boehringer Ingelheim Investigational Site
  - Stara Zagora, Bulgaria
    - 1160.26.0626 Boehringer Ingelheim Investigational Site
  - Varna, Bulgaria
    - 1160.26.0621 Boehringer Ingelheim Investigational Site
Canada
- Alberta
  - Calgary, Alberta, Canada
    - 1160.26.0694 Boehringer Ingelheim Investigational Site
  - Calgary, Alberta, Canada
    - 1160.26.0696 Boehringer Ingelheim Investigational Site
- British Columbia
  - Coquitlam, British Columbia, Canada
    - 1160.26.0680 Boehringer Ingelheim Investigational Site
  - Coquitlam, British Columbia, Canada
    - 1160.26.0712 Boehringer Ingelheim Investigational Site
  - Kelowna, British Columbia, Canada
    - 1160.26.0706 Boehringer Ingelheim Investigational Site
  - Nanaimo, British Columbia, Canada
    - 1160.26.0725 Boehringer Ingelheim Investigational Site
  - New Westminster, British Columbia, Canada
    - 1160.26.0691 Boehringer Ingelheim Investigational Site
  - Victoria, British Columbia, Canada
    - 1160.26.0714 Boehringer Ingelheim Investigational Site
- Manitoba
  - Portage la Prairie, Manitoba, Canada
    - 1160.26.0701 Boehringer Ingelheim Investigational Site
  - Winnipeg, Manitoba, Canada
    - 1160.26.0698 Boehringer Ingelheim Investigational Site
- Newfoundland and Labrador
  - Bay Roberts, Newfoundland and Labrador, Canada
    - 1160.26.0707 Boehringer Ingelheim Investigational Site
- Nova Scotia
  - Antigonish, Nova Scotia, Canada
    - 1160.26.0676 Boehringer Ingelheim Investigational Site
  - Halifax, Nova Scotia, Canada
    - 1160.26.0703 Boehringer Ingelheim Investigational Site
- Ontario
  - Ajax, Ontario, Canada
    - 1160.26.0679 Boehringer Ingelheim Investigational Site
  - Brampton, Ontario, Canada
    - 1160.26.0677 Boehringer Ingelheim Investigational Site
  - Burlington, Ontario, Canada
    - 1160.26.0674 Boehringer Ingelheim Investigational Site
  - Cambridge, Ontario, Canada
    - 1160.26.0702 Boehringer Ingelheim Investigational Site
  - Cambridge, Ontario, Canada
    - 1160.26.0720 Boehringer Ingelheim Investigational Site
  - Etobicoke, Ontario, Canada
    - 1160.26.0671 Clinical Research & Diagnostic Solutions Inc.
  - Grimsby, Ontario, Canada
    - 1160.26.0692 Boehringer Ingelheim Investigational Site
  - Hamilton, Ontario, Canada
    - 1160.26.0685 Boehringer Ingelheim Investigational Site
  - Hamilton, Ontario, Canada
    - 1160.26.0697 Boehringer Ingelheim Investigational Site
  - Hamilton, Ontario, Canada
    - 1160.26.0710 Boehringer Ingelheim Investigational Site
  - Hamilton, Ontario, Canada
    - 1160.26.0719 Boehringer Ingelheim Investigational Site
  - Hamilton, Ontario, Canada
    - 1160.26.0721 Boehringer Ingelheim Investigational Site
  - Kitchener, Ontario, Canada
    - 1160.26.0689 Boehringer Ingelheim Investigational Site
  - Mississauga, Ontario, Canada
    - 1160.26.0695 Boehringer Ingelheim Investigational Site
  - Mississauga, Ontario, Canada
    - 1160.26.0708 Boehringer Ingelheim Investigational Site
  - Mississauga, Ontario, Canada
    - 1160.26.0724 Boehringer Ingelheim Investigational Site
  - Newmarket, Ontario, Canada
    - 1160.26.0688 Boehringer Ingelheim Investigational Site
  - Oshawa, Ontario, Canada
    - 1160.26.0672 Boehringer Ingelheim Investigational Site
  - Ottawa, Ontario, Canada
    - 1160.26.0687 Boehringer Ingelheim Investigational Site
  - Scarborough, Ontario, Canada
    - 1160.26.0723 Boehringer Ingelheim Investigational Site
  - Sudbury, Ontario, Canada
    - 1160.26.0715 Boehringer Ingelheim Investigational Site
  - Thunder Bay, Ontario, Canada
    - 1160.26.0690 Boehringer Ingelheim Investigational Site
  - Toronto, Ontario, Canada
    - 1160.26.0684 Boehringer Ingelheim Investigational Site
  - Toronto, Ontario, Canada
    - 1160.26.0718 Boehringer Ingelheim Investigational Site
  - Waterloo, Ontario, Canada
    - 1160.26.0711 Boehringer Ingelheim Investigational Site
  - Windsor, Ontario, Canada
    - 1160.26.0686 Boehringer Ingelheim Investigational Site
- Quebec
  - Longueuil, Quebec, Canada
    - 1160.26.0693 Boehringer Ingelheim Investigational Site
  - Montreal, Quebec, Canada
    - 1160.26.0681 Boehringer Ingelheim Investigational Site
  - Montreal, Quebec, Canada
    - 1160.26.0683 Boehringer Ingelheim Investigational Site
  - Montreal, Quebec, Canada
    - 1160.26.0705 Boehringer Ingelheim Investigational Site
  - Montreal, Quebec, Canada
    - 1160.26.0709 Boehringer Ingelheim Investigational Site
  - Montreal, Quebec, Canada
    - 1160.26.0716 Boehringer Ingelheim Investigational Site
  - Quebec City, Quebec, Canada
    - 1160.26.0717 Boehringer Ingelheim Investigational Site
  - Saint George-de-Beauce, Quebec, Canada
    - 1160.26.0713 Boehringer Ingelheim Investigational Site
  - Saint Jerome, Quebec, Canada
    - 1160.26.0704 Boehringer Ingelheim Investigational Site
  - St. Charles-Borromee, Quebec, Canada
    - 1160.26.0699 Boehringer Ingelheim Investigational Site
  - St. Hyacinthe, Quebec, Canada
    - 1160.26.0675 Boehringer Ingelheim Investigational Site
  - Ste-Foy, Quebec, Canada
    - 1160.26.0700 Boehringer Ingelheim Investigational Site
  - Terrebonne (Lachenaie), Quebec, Canada
    - 1160.26.0682 Boehringer Ingelheim Investigational Site
- Saskatchewan
  - Saskatoon, Saskatchewan, Canada
    - 1160.26.0673 Boehringer Ingelheim Investigational Site
  - Saskatoon, Saskatchewan, Canada
    - 1160.26.0678 Boehringer Ingelheim Investigational Site
China
- - Beijing, China
    - 1160.26.0771 Boehringer Ingelheim Investigational Site
  - Beijing, China
    - 1160.26.0772 Boehringer Ingelheim Investigational Site
  - Beijing, China
    - 1160.26.0773 Boehringer Ingelheim Investigational Site
  - Beijing, China
    - 1160.26.0774 Boehringer Ingelheim Investigational Site
  - Beijing, China
    - 1160.26.0775 Boehringer Ingelheim Investigational Site
  - Beijing, China
    - 1160.26.0783 Boehringer Ingelheim Investigational Site
  - Hangzhou, China
    - 1160.26.0784 Boehringer Ingelheim Investigational Site
  - Harbin, China
    - 1160.26.0776 Boehringer Ingelheim Investigational Site
  - QingDao, China
    - 1160.26.0778 Boehringer Ingelheim Investigational Site
  - Shanghai, China
    - 1160.26.0781 Boehringer Ingelheim Investigational Site
  - Shanghai, China
    - 1160.26.0782 Boehringer Ingelheim Investigational Site
  - Shenyang, China
    - 1160.26.0777 Boehringer Ingelheim Investigational Site
  - Shijiazhuang, China
    - 1160.26.0780 Boehringer Ingelheim Investigational Site
Colombia
- - Bogotá, Colombia
    - 1160.26.0801 Boehringer Ingelheim Investigational Site
  - Bogotá, Colombia
    - 1160.26.0802 Boehringer Ingelheim Investigational Site
  - Bogotá, Colombia
    - 1160.26.0803 Boehringer Ingelheim Investigational Site
Czechia
- - Brno, Czechia
    - 1160.26.0815 Boehringer Ingelheim Investigational Site
  - Brno, Czechia
    - 1160.26.0816 Boehringer Ingelheim Investigational Site
  - Ostrava 1, Czechia
    - 1160.26.0820 Boehringer Ingelheim Investigational Site
  - Pardubice, Czechia
    - 1160.26.0818 Boehringer Ingelheim Investigational Site
  - Plzen-Bory, Czechia
    - 1160.26.0814 Boehringer Ingelheim Investigational Site
  - Pragha 9, Czechia
    - 1160.26.0813 Boehringer Ingelheim Investigational Site
  - Prague 5, Czechia
    - 1160.26.0811 Boehringer Ingelheim Investigational Site
  - Praha 6, Czechia
    - 1160.26.0812 Boehringer Ingelheim Investigational Site
  - Pribram, Czechia
    - 1160.26.0817 Boehringer Ingelheim Investigational Site
  - Usti nad Orlici, Czechia
    - 1160.26.0819 Boehringer Ingelheim Investigational Site
Denmark
- - Aalborg, Denmark
    - 1160.26.0837 Boehringer Ingelheim Investigational Site
  - Aarhus C, Denmark
    - 1160.26.0835 Boehringer Ingelheim Investigational Site
  - Frederikssund, Denmark
    - 1160.26.0838 Boehringer Ingelheim Investigational Site
  - Helsingør, Denmark
    - 1160.26.0833 Boehringer Ingelheim Investigational Site
  - Herlev, Denmark
    - 1160.26.0834 Boehringer Ingelheim Investigational Site
  - Horsens, Denmark
    - 1160.26.0841 Boehringer Ingelheim Investigational Site
  - Hvidovre, Denmark
    - 1160.26.0832 Boehringer Ingelheim Investigational Site
  - Køge, Denmark
    - 1160.26.0840 Boehringer Ingelheim Investigational Site
  - Odense, Denmark
    - 1160.26.0831 Boehringer Ingelheim Investigational Site
  - Roskilde, Denmark
    - 1160.26.0839 Boehringer Ingelheim Investigational Site
  - Svendborg, Denmark
    - 1160.26.0836 Boehringer Ingelheim Investigational Site
Finland
- - Espoo, Finland
    - 1160.26.0856 Boehringer Ingelheim Investigational Site
  - HUS, Finland
    - 1160.26.0851 Boehringer Ingelheim Investigational Site
  - Jyväskylä, Finland
    - 1160.26.0859 Boehringer Ingelheim Investigational Site
  - Kuopio, Finland
    - 1160.26.0855 Boehringer Ingelheim Investigational Site
  - Lappeenranta, Finland
    - 1160.26.0857 Boehringer Ingelheim Investigational Site
  - OYS, Finland
    - 1160.26.0854 Boehringer Ingelheim Investigational Site
  - Pori, Finland
    - 1160.26.0858 Boehringer Ingelheim Investigational Site
  - Tampere, Finland
    - 1160.26.0852 Boehringer Ingelheim Investigational Site
  - Turku, Finland
    - 1160.26.0853 Boehringer Ingelheim Investigational Site
France
- - ABBEVILLE cedex, France
    - 1160.26.0875A Boehringer Ingelheim Investigational Site
  - Angers, France
    - 1160.26.0882A Boehringer Ingelheim Investigational Site
  - Angers, France
    - 1160.26.0882B Boehringer Ingelheim Investigational Site
  - Angers, France
    - 1160.26.0882C Boehringer Ingelheim Investigational Site
  - Angers, France
    - 1160.26.0882D Boehringer Ingelheim Investigational Site
  - Angers, France
    - 1160.26.0882E Boehringer Ingelheim Investigational Site
  - Angers, France
    - 1160.26.0882G Boehringer Ingelheim Investigational Site
  - Angers, France
    - 1160.26.0882H Boehringer Ingelheim Investigational Site
  - Angers, France
    - 1160.26.0882I Boehringer Ingelheim Investigational Site
  - Angers, France
    - 1160.26.0882K Boehringer Ingelheim Investigational Site
  - Angers, France
    - 1160.26.0882L Boehringer Ingelheim Investigational Site
  - Angers, France
    - 1160.26.0884A Boehringer Ingelheim Investigational Site
  - Cholet, France
    - 1160.26.0887A Boehringer Ingelheim Investigational Site
  - Gap, France
    - 1160.26.0889A Boehringer Ingelheim Investigational Site
  - Grenoble, France
    - 1160.26.0888A Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0879A Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0879B Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0879C Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0879E Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0879F Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0879G Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0879H Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0879S Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0880A Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0880F Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0880G Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0880J Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0881A Boehringer Ingelheim Investigational Site
  - Joue les Tours, France
    - 1160.26.0881D Boehringer Ingelheim Investigational Site
  - Joué les Tours, France
    - 1160.26.0880B Boehringer Ingelheim Investigational Site
  - Joué les Tours, France
    - 1160.26.0880C Boehringer Ingelheim Investigational Site
  - Joué les Tours, France
    - 1160.26.0880D Boehringer Ingelheim Investigational Site
  - Joué les Tours, France
    - 1160.26.0880E Boehringer Ingelheim Investigational Site
  - Langres, France
    - 1160.26.0874A Boehringer Ingelheim Investigational Site
  - Langres, France
    - 1160.26.0874B Boehringer Ingelheim Investigational Site
  - Paris, France
    - 1160.26.0871A Boehringer Ingelheim Investigational Site
  - TOULOUSE cedex, France
    - 1160.26.0873A Boehringer Ingelheim Investigational Site
  - Tourcoing, France
    - 1160.26.0886A Boehringer Ingelheim Investigational Site
  - VALENCIENNES cedex, France
    - 1160.26.0872A Boehringer Ingelheim Investigational Site
  - Valenciennes, France
    - 1160.26.0872B Boehringer Ingelheim Investigational Site
  - Valenciennes cedex, France
    - 1160.26.0872C Boehringer Ingelheim Investigational Site
Germany
- - Berlin, Germany
    - 1160.26.0932 Boehringer Ingelheim Investigational Site
  - Berlin, Germany
    - 1160.26.0948 Boehringer Ingelheim Investigational Site
  - Berlin, Germany
    - 1160.26.0962 Boehringer Ingelheim Investigational Site
  - Bochum, Germany
    - 1160.26.0940 Boehringer Ingelheim Investigational Site
  - Coburg, Germany
    - 1160.26.0936 Boehringer Ingelheim Investigational Site
  - Dachau, Germany
    - 1160.26.0968 Boehringer Ingelheim Investigational Site
  - Dortmund, Germany
    - 1160.26.0972 Boehringer Ingelheim Investigational Site
  - Duisburg, Germany
    - 1160.26.0957 Boehringer Ingelheim Investigational Site
  - Erlangen, Germany
    - 1160.26.0971 Boehringer Ingelheim Investigational Site
  - Eschweiler, Germany
    - 1160.26.0965 Boehringer Ingelheim Investigational Site
  - Essen, Germany
    - 1160.26.0934 Boehringer Ingelheim Investigational Site
  - Frankfurt/Main, Germany
    - 1160.26.0931 Boehringer Ingelheim Investigational Site
  - Heidelberg, Germany
    - 1160.26.0943 Boehringer Ingelheim Investigational Site
  - Kassel, Germany
    - 1160.26.0955 Boehringer Ingelheim Investigational Site
  - Köln, Germany
    - 1160.26.0963 Boehringer Ingelheim Investigational Site
  - Lahr, Germany
    - 1160.26.0946 Boehringer Ingelheim Investigational Site
  - Limburg, Germany
    - 1160.26.0944 Boehringer Ingelheim Investigational Site
  - Mainz, Germany
    - 1160.26.0951 Boehringer Ingelheim Investigational Site
  - Mannheim, Germany
    - 1160.26.0933 Boehringer Ingelheim Investigational Site
  - Mannheim, Germany
    - 1160.26.0945 Boehringer Ingelheim Investigational Site
  - Mannheim, Germany
    - 1160.26.0970 Boehringer Ingelheim Investigational Site
  - München, Germany
    - 1160.26.0947 Boehringer Ingelheim Investigational Site
  - München, Germany
    - 1160.26.0952 Boehringer Ingelheim Investigational Site
  - Papenburg, Germany
    - 1160.26.0941 Boehringer Ingelheim Investigational Site
  - Suhl, Germany
    - 1160.26.0959 Boehringer Ingelheim Investigational Site
  - Witten, Germany
    - 1160.26.0937 Boehringer Ingelheim Investigational Site
  - Wuppertal, Germany
    - 1160.26.0966 Boehringer Ingelheim Investigational Site
Greece
- - Alexandroupolis, Greece
    - 1160.26.0908 University Hospital of Alexandroupolis
  - Athens, Greece
    - 1160.26.0901 General Hospital "Alexandra", Therapeutic Clinic UOA
  - Athens, Greece
    - 1160.26.0906 General Hospital ";Evangelismos"
  - Athens, Greece
    - 1160.26.0907 "Pammakaristos" Hospital of Athens
  - Athens, Greece
    - 1160.26.0915 "Hippokratio" Hospital of Athens
  - Kalamaria-Thessaloniki, Greece
    - 1160.26.0914 2nd IKA Hospital, Thessaloniki
  - Larissa, Greece
    - 1160.26.0904 General Hospital of Larissa
  - Larissa, Greece
    - 1160.26.0913 University Hospital of Larissa
  - Leivadia, Greece
    - 1160.26.0912 General Hospital of Leivadia
  - Thessaloniki, Greece
    - 1160.26.0902 General Hospital " Papageorgiou"
  - Thiva, Greece
    - 1160.26.0910 General Hospital of Thiva
  - Trikala, Greece
    - 1160.26.0903 General Hospital of Trikala
  - Voula - Athens, Greece
    - 1160.26.0905 Boehringer Ingelheim Investigational Site
Hong Kong
- - Hong Kong, Hong Kong
    - 1160.26.1001 Boehringer Ingelheim Investigational Site
  - Hong Kong, Hong Kong
    - 1160.26.1002 Boehringer Ingelheim Investigational Site
  - Kowloon, Hong Kong
    - 1160.26.1003 Boehringer Ingelheim Investigational Site
  - Kowloon, Hong Kong
    - 1160.26.1004 Boehringer Ingelheim Investigational Site
Hungary
- - Budapest, Hungary
    - 1160.26.1011 Boehringer Ingelheim Investigational Site
  - Budapest, Hungary
    - 1160.26.1012 Boehringer Ingelheim Investigational Site
  - Budapest, Hungary
    - 1160.26.1013 Boehringer Ingelheim Investigational Site
  - Budapest, Hungary
    - 1160.26.1014 Boehringer Ingelheim Investigational Site
  - Budapest, Hungary
    - 1160.26.1015 Boehringer Ingelheim Investigational Site
  - Budapest, Hungary
    - 1160.26.1016 Boehringer Ingelheim Investigational Site
  - Gyongyos, Hungary
    - 1160.26.1020 Boehringer Ingelheim Investigational Site
  - Komarom, Hungary
    - 1160.26.1017 Boehringer Ingelheim Investigational Site
  - Pecs, Hungary
    - 1160.26.1018 Boehringer Ingelheim Investigational Site
  - Veszprem, Hungary
    - 1160.26.1019 Boehringer Ingelheim Investigational Site
India
- - Ahmedabad, India
    - 1160.26.1056 Boehringer Ingelheim Investigational Site
  - Ahmedabad, India
    - 1160.26.1057 Boehringer Ingelheim Investigational Site
  - Bangalore, India
    - 1160.26.1064 Boehringer Ingelheim Investigational Site
  - Bangalore, India
    - 1160.26.1065 Boehringer Ingelheim Investigational Site
  - Bikaner, India
    - 1160.26.1071 Boehringer Ingelheim Investigational Site
  - Chennai, India
    - 1160.26.1066 Boehringer Ingelheim Investigational Site
  - Coimbatore, India
    - 1160.26.1069 Boehringer Ingelheim Investigational Site
  - Hyderabad, India
    - 1160.26.1062 Boehringer Ingelheim Investigational Site
  - Indore, India
    - 1160.26.1058 Boehringer Ingelheim Investigational Site
  - Jaipur, India
    - 1160.26.1053 Boehringer Ingelheim Investigational Site
  - Jaipur, India
    - 1160.26.1073 Boehringer Ingelheim Investigational Site
  - Kerala, India
    - 1160.26.1067 Boehringer Ingelheim Investigational Site
  - Kottayam, India
    - 1160.26.1068 Boehringer Ingelheim Investigational Site
  - Lucknow, India
    - 1160.26.1055 Boehringer Ingelheim Investigational Site
  - Ludhiana, India
    - 1160.26.1051 Boehringer Ingelheim Investigational Site
  - Mumbai, India
    - 1160.26.1060 Boehringer Ingelheim Investigational Site
  - Mysore, India
    - 1160.26.1072 Boehringer Ingelheim Investigational Site
  - Nagpur, India
    - 1160.26.1059 Boehringer Ingelheim Investigational Site
  - New Delhi, India
    - 1160.26.1052 Boehringer Ingelheim Investigational Site
  - Pune, India
    - 1160.26.1070 Boehringer Ingelheim Investigational Site
Israel
- - Afula, Israel
    - 1160.26.1110 Boehringer Ingelheim Investigational Site
  - Afula, Israel
    - 1160.26.1121 Boehringer Ingelheim Investigational Site
  - Ashkelon, Israel
    - 1160.26.1111 Boehringer Ingelheim Investigational Site
  - Be´er Scheva, Israel
    - 1160.26.1102 Boehringer Ingelheim Investigational Site
  - Givatayim, Israel
    - 1160.26.1117 Boehringer Ingelheim Investigational Site
  - Hadera, Israel
    - 1160.26.1112 Boehringer Ingelheim Investigational Site
  - Haifa, Israel
    - 1160.26.1091 Boehringer Ingelheim Investigational Site
  - Haifa, Israel
    - 1160.26.1113 Boehringer Ingelheim Investigational Site
  - Haifa, Israel
    - 1160.26.1114 Boehringer Ingelheim Investigational Site
  - Haifa, Israel
    - 1160.26.1116 Boehringer Ingelheim Investigational Site
  - Haifa, Israel
    - 1160.26.1118 Boehringer Ingelheim Investigational Site
  - Holon, Israel
    - 1160.26.1105 Boehringer Ingelheim Investigational Site
  - Jerusalem, Israel
    - 1160.26.1097 Boehringer Ingelheim Investigational Site
  - Jerusalem, Israel
    - 1160.26.1101 Boehringer Ingelheim Investigational Site
  - Jerusalem, Israel
    - 1160.26.1104 Boehringer Ingelheim Investigational Site
  - Jerusalem, Israel
    - 1160.26.1106 Boehringer Ingelheim Investigational Site
  - Kfar Saba, Israel
    - 1160.26.1119 Boehringer Ingelheim Investigational Site
  - Nazareth, Israel
    - 1160.26.1115 Boehringer Ingelheim Investigational Site
  - Petah Tikva, Israel
    - 1160.26.1096 Boehringer Ingelheim Investigational Site
  - Ramat Gan, Israel
    - 1160.26.1093 Boehringer Ingelheim Investigational Site
  - Ramat Gan, Israel
    - 1160.26.1094 Boehringer Ingelheim Investigational Site
  - Ramat Gan, Israel
    - 1160.26.1095 Boehringer Ingelheim Investigational Site
  - Rehovot, Israel
    - 1160.26.1100 Boehringer Ingelheim Investigational Site
  - Safed, Israel
    - 1160.26.1103 Boehringer Ingelheim Investigational Site
  - Tel Hashomer, Israel
    - 1160.26.1092 Boehringer Ingelheim Investigational Site
  - Tel Hashomer, Israel
    - 1160.26.1098 Boehringer Ingelheim Investigational Site
  - Tel-Aviv, Israel
    - 1160.26.1107 Boehringer Ingelheim Investigational Site
  - Tel-Aviv, Israel
    - 1160.26.1108 Boehringer Ingelheim Investigational Site
  - Tel-Aviv, Israel
    - 1160.26.1109 Boehringer Ingelheim Investigational Site
  - Tel-Aviv, Israel
    - 1160.26.1120 Boehringer Ingelheim Investigational Site
  - Tel-Aviv, Israel
    - 1160.26.1122 Boehringer Ingelheim Investigational Site
  - Zerifin, Israel
    - 1160.26.1099 Boehringer Ingelheim Investigational Site
Italy
- - Arezzo, Italy
    - 1160.26.1169 Boehringer Ingelheim Investigational Site
  - Ascoli Piceno, Italy
    - 1160.26.1172 Boehringer Ingelheim Investigational Site
  - Bentivoglio (BO), Italy
    - 1160.26.1180 Boehringer Ingelheim Investigational Site
  - Bologna, Italy
    - 1160.26.1161 Boehringer Ingelheim Investigational Site
  - Castelnuovo Garfagnana, Italy
    - 1160.26.1163 Boehringer Ingelheim Investigational Site
  - Chieti, Italy
    - 1160.26.1178 Boehringer Ingelheim Investigational Site
  - Colleferro, Italy
    - 1160.26.1171 Boehringer Ingelheim Investigational Site
  - Cremona, Italy
    - 1160.26.1174 Boehringer Ingelheim Investigational Site
  - Eboli, Italy
    - 1160.26.1167 Boehringer Ingelheim Investigational Site
  - Isernia, Italy
    - 1160.26.1168 Boehringer Ingelheim Investigational Site
  - Legnago, Italy
    - 1160.26.1162 Boehringer Ingelheim Investigational Site
  - Mantova, Italy
    - 1160.26.1177 Boehringer Ingelheim Investigational Site
  - Perugia SAN Sisto, Italy
    - 1160.26.1165 Boehringer Ingelheim Investigational Site
  - Roma, Italy
    - 1160.26.1175 Boehringer Ingelheim Investigational Site
  - San Bonifacio, Italy
    - 1160.26.1181 Boehringer Ingelheim Investigational Site
  - San Daniele Del Friuli, Italy
    - 1160.26.1173 Boehringer Ingelheim Investigational Site
  - Sassari, Italy
    - 1160.26.1170 Boehringer Ingelheim Investigational Site
  - Sassari, Italy
    - 1160.26.1176 Boehringer Ingelheim Investigational Site
Japan
- - Abeno-ku, Osaka, Osaka, Japan
    - 1160.26.1204 Boehringer Ingelheim Investigational Site
  - Aki-gun, Hiroshima, Japan
    - 1160.26.1209 Boehringer Ingelheim Investigational Site
  - Aoba-ku, Sendai, Miyagi, Japan
    - 1160.26.1193 Boehringer Ingelheim Investigational Site
  - Chuo-ku, Fukuoka, Fukuoka, Japan
    - 1160.26.1211 Boehringer Ingelheim Investigational Site
  - Chuo-ku, Fukuoka, Fukuoka, Japan
    - 1160.26.1225 Boehringer Ingelheim Investigational Site
  - Chuo-ku, Kobe, Hyogo, Japan
    - 1160.26.1221 Boehringer Ingelheim Investigational Site
  - Chuo-ku, Osaka, Osaka, Japan
    - 1160.26.1219 Boehringer Ingelheim Investigational Site
  - Fujioka-shi , Gunma-ken, Japan
    - 1160.26.1229 Boehringer Ingelheim Investigational Site
  - Fukushima-shi,Fukushima-ken, Japan
    - 1160.26.1232 Boehringer Ingelheim Investigational Site
  - Higashimatsushimashi, Miyagi-ken, Japan
    - 1160.26.1228 Boehringer Ingelheim Investigational Site
  - Himeji, Hyogo, Japan
    - 1160.26.1208 Boehringer Ingelheim Investigational Site
  - Iida, Nagano, Japan
    - 1160.26.1214 Boehringer Ingelheim Investigational Site
  - Isesaki-shi,Gunma, Japan
    - 1160.26.1240 Boehringer Ingelheim Investigational Site
  - Iwakuni, Yamaguchi, Japan
    - 1160.26.1224 Boehringer Ingelheim Investigational Site
  - Izumi-ku, Sendai, Miyagi, Japan
    - 1160.26.1194 Boehringer Ingelheim Investigational Site
  - Kamigyo-ku, Kyoto, Japan
    - 1160.26.1241 Boehringer Ingelheim Investigational Site
  - Kawachinagano, Osaka, Japan
    - 1160.26.1220 Boehringer Ingelheim Investigational Site
  - Kita-ku, Osaka, Osaka, Japan
    - 1160.26.1203 Boehringer Ingelheim Investigational Site
  - Kita-ku, Sakai, Osaka, Japan
    - 1160.26.1207 Boehringer Ingelheim Investigational Site
  - Komatsu-shi,Ishikawa -ken, Japan
    - 1160.26.1231 Boehringer Ingelheim Investigational Site
  - Kyoto-shi,Kyoto, Japan
    - 1160.26.1233 Boehringer Ingelheim Investigational Site
  - Matsumoto, Nagano, Japan
    - 1160.26.1242 Boehringer Ingelheim Investigational Site
  - Minami-ku, Fukuoka, Fukuoka, Japan
    - 1160.26.1210 Boehringer Ingelheim Investigational Site
  - Minato, Tokyo, Japan
    - 1160.26.1218 Boehringer Ingelheim Investigational Site
  - Minato-ku, Nagoya, Aichi, Japan
    - 1160.26.1200 Boehringer Ingelheim Investigational Site
  - Minato-ku, Nagoya, Aichi, Japan
    - 1160.26.1201 Boehringer Ingelheim Investigational Site
  - Narashino, Chiba, Japan
    - 1160.26.1216 Boehringer Ingelheim Investigational Site
  - Nishinomiya-shi,Hyogo, Japan
    - 1160.26.1237 Boehringer Ingelheim Investigational Site
  - Okayama, Okayama, Japan
    - 1160.26.1223 Boehringer Ingelheim Investigational Site
  - Oota, Tokyo, Japan
    - 1160.26.1197 Boehringer Ingelheim Investigational Site
  - Otaru, Hokkaido, Japan
    - 1160.26.1212 Boehringer Ingelheim Investigational Site
  - Sagamihara, Kanagawa-ken, Japan
    - 1160.26.1230 Boehringer Ingelheim Investigational Site
  - Sapporo-shi,Hokkai-do, Japan
    - 1160.26.1238 Boehringer Ingelheim Investigational Site
  - Shibuya, Tokyo, Japan
    - 1160.26.1217 Boehringer Ingelheim Investigational Site
  - Shinjuku, Tokyo, Japan
    - 1160.26.1196 Boehringer Ingelheim Investigational Site
  - Shiroishi-ku, Sapporo, Hokkaido, Japan
    - 1160.26.1191 Boehringer Ingelheim Investigational Site
  - Shiroishi-ku, Sapporo, Hokkaido, Japan
    - 1160.26.1192 Boehringer Ingelheim Investigational Site
  - Suita, Osaka, Japan
    - 1160.26.1206 Boehringer Ingelheim Investigational Site
  - Suita-shi, Osaka, Japan
    - 1160.26.1235 Boehringer Ingelheim Investigational Site
  - Suita-shi, Osaka, Japan
    - 1160.26.1236 Boehringer Ingelheim Investigational Site
  - Sumiyoshi-ku, Osaka, Osaka, Japan
    - 1160.26.1205 Boehringer Ingelheim Investigational Site
  - Takatsuki-shi,Osaka, Japan
    - 1160.26.1234 Boehringer Ingelheim Investigational Site
  - Tokorozawa, Saitama, Japan
    - 1160.26.1215 Boehringer Ingelheim Investigational Site
  - Totsuka-ku, Yokohama, Kanagawa, Japan
    - 1160.26.1198 Boehringer Ingelheim Investigational Site
  - Tsuchiura, Ibaragi, Japan
    - 1160.26.1195 Boehringer Ingelheim Investigational Site
  - Ueda, Nagano, Japan
    - 1160.26.1199 Boehringer Ingelheim Investigational Site
  - Wakayama, Wakayama, Japan
    - 1160.26.1222 Boehringer Ingelheim Investigational Site
  - Yanagawa, Fukuoka, Japan
    - 1160.26.1227 Boehringer Ingelheim Investigational Site
  - Yao, Osaka, Japan
    - 1160.26.1243 Boehringer Ingelheim Investigational Site
Korea, Republic of
- - Busan, Korea, Republic of
    - 1160.26.1585 Boehringer Ingelheim Investigational Site
  - Chungchungnam-Do, Korea, Republic of
    - 1160.26.1586 Boehringer Ingelheim Investigational Site
  - Daegu, Korea, Republic of
    - 1160.26.1584 Boehringer Ingelheim Investigational Site
  - Daegu, Korea, Republic of
    - 1160.26.1591 Boehringer Ingelheim Investigational Site
  - Gwangju, Korea, Republic of
    - 1160.26.1590 Boehringer Ingelheim Investigational Site
  - Incheon, Korea, Republic of
    - 1160.26.1581 Boehringer Ingelheim Investigational Site
  - Seoul, Korea, Republic of
    - 1160.26.1582 Boehringer Ingelheim Investigational Site
  - Seoul, Korea, Republic of
    - 1160.26.1583 Boehringer Ingelheim Investigational Site
  - Seoul, Korea, Republic of
    - 1160.26.1588 Boehringer Ingelheim Investigational Site
  - Seoul, Korea, Republic of
    - 1160.26.1589 Boehringer Ingelheim Investigational Site
  - Seoul, Korea, Republic of
    - 1160.26.1592 Boehringer Ingelheim Investigational Site
  - Seoul, Korea, Republic of
    - 1160.26.1593 Boehringer Ingelheim Investigational Site
Malaysia
- - Kajang,Selangor, Malaysia
    - 1160.26.1297 Boehringer Ingelheim Investigational Site
  - Kuala Lumpur, Malaysia
    - 1160.26.1291 Boehringer Ingelheim Investigational Site
  - Kuala Lumpur, Malaysia
    - 1160.26.1292 Boehringer Ingelheim Investigational Site
  - Kuala Lumpur, Malaysia
    - 1160.26.1294 Boehringer Ingelheim Investigational Site
  - Kuching, Malaysia
    - 1160.26.1293 Boehringer Ingelheim Investigational Site
  - Penang, Malaysia
    - 1160.26.1295 Boehringer Ingelheim Investigational Site
  - Penang, Malaysia
    - 1160.26.1296 Boehringer Ingelheim Investigational Site
Mexico
- - Durango, Mexico
    - 1160.26.1318 Hospital General "Dr. Santiago Ramón y Cajal
  - Guadalajara, Mexico
    - 1160.26.1311 Hospital Mexico-Americano
  - Guadalajara, Mexico
    - 1160.26.1317 hOSPITAL bERNARDETTE
  - Mexico, Mexico
    - 1160.26.1312 Hospital de Jesus
  - Mexico, Mexico
    - 1160.26.1319 Instituto Nacional de Cardiologia
  - México, Mexico
    - 1160.26.1314 Hospital 1o. de Octubre
  - San Luis Potosí, Mexico
    - 1160.26.1313 Hosp. Angeles Centro Medico del Potosi
  - San Luis Potosí, Mexico
    - 1160.26.1322 Hospital Central "Dr. Ignacio Morones Prieto"
Netherlands
- - Almelo, Netherlands
    - 1160.26.1344 Boehringer Ingelheim Investigational Site
  - Amsterdam, Netherlands
    - 1160.26.1331 Boehringer Ingelheim Investigational Site
  - Apeldoorn, Netherlands
    - 1160.26.1336 Boehringer Ingelheim Investigational Site
  - Breda, Netherlands
    - 1160.26.1332 Boehringer Ingelheim Investigational Site
  - Den Bosch, Netherlands
    - 1160.26.1337 Boehringer Ingelheim Investigational Site
  - Den Helder, Netherlands
    - 1160.26.1349 Boehringer Ingelheim Investigational Site
  - Deventer, Netherlands
    - 1160.26.1345 Boehringer Ingelheim Investigational Site
  - Dirksland, Netherlands
    - 1160.26.1360 Boehringer Ingelheim Investigational Site
  - Dordrecht, Netherlands
    - 1160.26.1348 Boehringer Ingelheim Investigational Site
  - Ede, Netherlands
    - 1160.26.1340 Boehringer Ingelheim Investigational Site
  - Eindhoven, Netherlands
    - 1160.26.1358 Boehringer Ingelheim Investigational Site
  - Enschede, Netherlands
    - 1160.26.1338 Boehringer Ingelheim Investigational Site
  - Goes, Netherlands
    - 1160.26.1343 Boehringer Ingelheim Investigational Site
  - Gorinchem, Netherlands
    - 1160.26.1347 Boehringer Ingelheim Investigational Site
  - Groningen, Netherlands
    - 1160.26.1333 Boehringer Ingelheim Investigational Site
  - Groningen, Netherlands
    - 1160.26.1355 Boehringer Ingelheim Investigational Site
  - Heerlen, Netherlands
    - 1160.26.1361 Boehringer Ingelheim Investigational Site
  - Hengelo, Netherlands
    - 1160.26.1339 Boehringer Ingelheim Investigational Site
  - Hilversum, Netherlands
    - 1160.26.1346 Boehringer Ingelheim Investigational Site
  - Hoorn, Netherlands
    - 1160.26.1356 Boehringer Ingelheim Investigational Site
  - Maastricht, Netherlands
    - 1160.26.1359 Boehringer Ingelheim Investigational Site
  - Meppel, Netherlands
    - 1160.26.1341 Boehringer Ingelheim Investigational Site
  - Rotterdam, Netherlands
    - 1160.26.1354 Boehringer Ingelheim Investigational Site
  - Sneek, Netherlands
    - 1160.26.1351 Boehringer Ingelheim Investigational Site
  - Spiijkenisse, Netherlands
    - 1160.26.1334 Boehringer Ingelheim Investigational Site
  - Terneuzen, Netherlands
    - 1160.26.1335 Boehringer Ingelheim Investigational Site
  - Tiel, Netherlands
    - 1160.26.1353 Boehringer Ingelheim Investigational Site
  - Tilburg, Netherlands
    - 1160.26.1352 Boehringer Ingelheim Investigational Site
  - Veldhoven, Netherlands
    - 1160.26.1350 Boehringer Ingelheim Investigational Site
  - Velp, Netherlands
    - 1160.26.1342 Boehringer Ingelheim Investigational Site
  - Venlo, Netherlands
    - 1160.26.1357 Boehringer Ingelheim Investigational Site
Norway
- - Gjøvik, Norway
    - 1160.26.1396 Boehringer Ingelheim Investigational Site
  - Moss, Norway
    - 1160.26.1393 Boehringer Ingelheim Investigational Site
  - Nordbyhagen, Norway
    - 1160.26.1395 Boehringer Ingelheim Investigational Site
  - Oslo, Norway
    - 1160.26.1391 Boehringer Ingelheim Investigational Site
  - Oslo, Norway
    - 1160.26.1392 Boehringer Ingelheim Investigational Site
  - Oslo, Norway
    - 1160.26.1397 Boehringer Ingelheim Investigational Site
  - RUD, Norway
    - 1160.26.1394 Boehringer Ingelheim Investigational Site
Peru
- - Bella Vista, Peru
    - 1160.26.1415 Hospital Alberto Sabogal
  - Jesús María, Peru
    - 1160.26.1411 Clinica San Felipe
  - San Isidro, Peru
    - 1160.26.1412 Clínica Anglo Americana
  - San Martín de Porres, Peru
    - 1160.26.1413 Hospital Cayetano Heredia
  - Urbanización Sto Tomas De San Borja, Peru
    - 1160.26.1414 Clínica Vesalio
Philippines
- - Manila, Philippines
    - 1160.26.1421 Philippine General Hospital
  - Manila, Philippines
    - 1160.26.1422 Manila Doctors Hospital
  - Pasig City, Philippines
    - 1160.26.1424 The Medical City
  - Quezon City, Philippines
    - 1160.26.1423 Philippine Heart Center
  - Quezon City, Philippines
    - 1160.26.1425 St Lukes Medical Center
Poland
- - Gdynia, Poland
    - 1160.26.1436 Boehringer Ingelheim Investigational Site
  - Gdynia, Poland
    - 1160.26.1438 Boehringer Ingelheim Investigational Site
  - Gdynia Redlowo, Poland
    - 1160.26.1437 Boehringer Ingelheim Investigational Site
  - Katowice, Poland
    - 1160.26.1435 Boehringer Ingelheim Investigational Site
  - Krakow, Poland
    - 1160.26.1439 Boehringer Ingelheim Investigational Site
  - Krakow, Poland
    - 1160.26.1440 Boehringer Ingelheim Investigational Site
  - Pulawy, Poland
    - 1160.26.1433 Boehringer Ingelheim Investigational Site
  - Warsaw, Poland
    - 1160.26.1431 Boehringer Ingelheim Investigational Site
  - Warsaw, Poland
    - 1160.26.1432 Boehringer Ingelheim Investigational Site
  - Zabrze, Poland
    - 1160.26.1434 Boehringer Ingelheim Investigational Site
Portugal
- - Amadora, Portugal
    - 1160.26.1456 Boehringer Ingelheim Investigational Site
  - Carnaxide, Portugal
    - 1160.26.1451 Boehringer Ingelheim Investigational Site
  - Coimbra, Portugal
    - 1160.26.1454 Boehringer Ingelheim Investigational Site
  - Coimbra, Portugal
    - 1160.26.1459 Boehringer Ingelheim Investigational Site
  - Covilhã, Portugal
    - 1160.26.1457 Boehringer Ingelheim Investigational Site
  - Lisboa, Portugal
    - 1160.26.1453 Boehringer Ingelheim Investigational Site
  - Lisboa, Portugal
    - 1160.26.1458 Boehringer Ingelheim Investigational Site
  - Porto, Portugal
    - 1160.26.1455 Boehringer Ingelheim Investigational Site
  - Setúbal, Portugal
    - 1160.26.1452 Boehringer Ingelheim Investigational Site
Romania
- - Bucharest, Romania
    - 1160.26.1471 Boehringer Ingelheim Investigational Site
  - Bucharest, Romania
    - 1160.26.1472 Boehringer Ingelheim Investigational Site
  - Cluj Napoca, Romania
    - 1160.26.1478 Boehringer Ingelheim Investigational Site
Russian Federation
- - Moscow, Russian Federation
    - 1160.26.1501 Boehringer Ingelheim Investigational Site
  - Moscow, Russian Federation
    - 1160.26.1502 Boehringer Ingelheim Investigational Site
  - Moscow, Russian Federation
    - 1160.26.1503 Boehringer Ingelheim Investigational Site
  - Moscow, Russian Federation
    - 1160.26.1504 Boehringer Ingelheim Investigational Site
  - Moscow, Russian Federation
    - 1160.26.1505 Boehringer Ingelheim Investigational Site
  - Moscow, Russian Federation
    - 1160.26.1506 Boehringer Ingelheim Investigational Site
  - Moscow, Russian Federation
    - 1160.26.1507 Boehringer Ingelheim Investigational Site
  - Moscow, Russian Federation
    - 1160.26.1508 Boehringer Ingelheim Investigational Site
  - Moscow, Russian Federation
    - 1160.26.1509 Boehringer Ingelheim Investigational Site
  - Moscow, Russian Federation
    - 1160.26.1510 Boehringer Ingelheim Investigational Site
  - Moscow, Russian Federation
    - 1160.26.1511 Boehringer Ingelheim Investigational Site
  - St. Petersburg, Russian Federation
    - 1160.26.1512 Boehringer Ingelheim Investigational Site
  - St. Petersburg, Russian Federation
    - 1160.26.1513 Boehringer Ingelheim Investigational Site
  - St. Petersburg, Russian Federation
    - 1160.26.1514 Boehringer Ingelheim Investigational Site
  - St. Petersburg, Russian Federation
    - 1160.26.1515 Boehringer Ingelheim Investigational Site
Singapore
- - Singapore, Singapore
    - 1160.26.1531 Boehringer Ingelheim Investigational Site
  - Singapore, Singapore
    - 1160.26.1532 Boehringer Ingelheim Investigational Site
Slovakia
- - Banska Bystrica, Slovakia
    - 1160.26.1548 Boehringer Ingelheim Investigational Site
  - Bratislava, Slovakia
    - 1160.26.1541 Boehringer Ingelheim Investigational Site
  - Bratislava, Slovakia
    - 1160.26.1542 Boehringer Ingelheim Investigational Site
  - Bratislava, Slovakia
    - 1160.26.1543 Boehringer Ingelheim Investigational Site
  - Bratislava, Slovakia
    - 1160.26.1544 Boehringer Ingelheim Investigational Site
  - Bratislava, Slovakia
    - 1160.26.1545 Boehringer Ingelheim Investigational Site
  - Bratislava, Slovakia
    - 1160.26.1546 Boehringer Ingelheim Investigational Site
  - Kosice, Slovakia
    - 1160.26.1549 Boehringer Ingelheim Investigational Site
  - Kosice, Slovakia
    - 1160.26.1550 Boehringer Ingelheim Investigational Site
  - Zilina, Slovakia
    - 1160.26.1547 Boehringer Ingelheim Investigational Site
South Africa
- - Bloemfontein, South Africa
    - 1160.26.1562 Boehringer Ingelheim Investigational Site
  - Boksburg, South Africa
    - 1160.26.1569 Boehringer Ingelheim Investigational Site
  - Cape Town, South Africa
    - 1160.26.1561 Boehringer Ingelheim Investigational Site
  - Johannesburg, South Africa
    - 1160.26.1564 Boehringer Ingelheim Investigational Site
  - Johannesburg, South Africa
    - 1160.26.1567 Boehringer Ingelheim Investigational Site
  - Johannesburg, South Africa
    - 1160.26.1568 Boehringer Ingelheim Investigational Site
  - Pretoria, South Africa
    - 1160.26.1566 Boehringer Ingelheim Investigational Site
  - Randburg, South Africa
    - 1160.26.1563 Boehringer Ingelheim Investigational Site
  - Somerset West, South Africa
    - 1160.26.1565 Boehringer Ingelheim Investigational Site
Spain
- - Barcelona, Spain
    - 1160.26.1601 Boehringer Ingelheim Investigational Site
  - Cadiz, Spain
    - 1160.26.1606 Boehringer Ingelheim Investigational Site
  - Fuenlabrada (Madrid), Spain
    - 1160.26.1607 Boehringer Ingelheim Investigational Site
  - Leganés, Madrid, Spain
    - 1160.26.1604 Boehringer Ingelheim Investigational Site
  - Madrid, Spain
    - 1160.26.1603 Boehringer Ingelheim Investigational Site
  - Madrid, Spain
    - 1160.26.1608 Boehringer Ingelheim Investigational Site
  - Madrid-San Lorenzo Del Escorial, Spain
    - 1160.26.1609 Boehringer Ingelheim Investigational Site
  - Móstoles (Madrid), Spain
    - 1160.26.1605 Boehringer Ingelheim Investigational Site
  - Sabadell, Spain
    - 1160.26.1602 Boehringer Ingelheim Investigational Site
Sweden
- - Göteboerg, Sweden
    - 1160.26.1633 Sahlgrenska Sjukhuset
  - Jönköping, Sweden
    - 1160.26.1629 AVK-mott, Spec.M1, Länssjukhuset Ryhov
  - Linköping, Sweden
    - 1160.26.1631 Universitetssjukhuset i Linköping
  - Malmö, Sweden
    - 1160.26.1627 Hjärtmott. ING 35, Malmö Universitetssjukhus MAS
  - Norrköping, Sweden
    - 1160.26.1625 Hjärtmott./Medicinkliniken, Vrinnevisjukhuset
  - Nässjö, Sweden
    - 1160.26.1628 Rådhusg. 29, Lars Mörlids Läkarmottagning
  - Stockholm, Sweden
    - 1160.26.1626 Hjärtkärllaboratoriet, Danderyds Sjukhus AB
  - Stockholm, Sweden
    - 1160.26.1632 Capio S:t Görans Sjukhus
  - Stockholm, Sweden
    - 1160.26.1634 Södersjukhuset
  - Umeå, Sweden
    - 1160.26.1624 Klin. forskningscentrum, Norrlands Universitetssjukhus
  - Uppsala, Sweden
    - 1160.26.1621 Kardiologiska kliniken, Akademiska Sjukhuset
  - Uppsala, Sweden
    - 1160.26.1635 UCR/Uppsala
  - Västerås, Sweden
    - 1160.26.1622 Hjärtmottagningen, Centrallasarettet
  - Örebro, Sweden
    - 1160.26.1623 Kardiologiska kliniken, Universitetssjukhuset
Switzerland
- - Basel, Switzerland
    - 1160.26.1652 Boehringer Ingelheim Investigational Site
  - Bellinzona, Switzerland
    - 1160.26.1655 Boehringer Ingelheim Investigational Site
  - Bern, Switzerland
    - 1160.26.1651 Boehringer Ingelheim Investigational Site
  - Lugano, Switzerland
    - 1160.26.1654 Boehringer Ingelheim Investigational Site
Taiwan
- - Changhua County, Taiwan
    - 1160.26.1680 Boehringer Ingelheim Investigational Site
  - Hualien, Taiwan
    - 1160.26.1683 Boehringer Ingelheim Investigational Site
  - Kaohsiung, Taiwan
    - 1160.26.1682 Boehringer Ingelheim Investigational Site
  - Taichung, Taiwan
    - 1160.26.1679 China Medical University Hospital
  - Tainan, Taiwan
    - 1160.26.1681 Boehringer Ingelheim Investigational Site
  - Taipei, Taiwan
    - 1160.26.1671 Boehringer Ingelheim Investigational Site
  - Taipei, Taiwan
    - 1160.26.1672 Boehringer Ingelheim Investigational Site
  - Taipei, Taiwan
    - 1160.26.1673 Boehringer Ingelheim Investigational Site
  - Taipei, Taiwan
    - 1160.26.1674 Boehringer Ingelheim Investigational Site
  - Taipei, Taiwan
    - 1160.26.1675 Boehringer Ingelheim Investigational Site
  - Taipei, Taiwan
    - 1160.26.1676 Boehringer Ingelheim Investigational Site
  - Taipei, Taiwan
    - 1160.26.1677 Boehringer Ingelheim Investigational Site
  - Taoyuan, Taiwan
    - 1160.26.1678 Boehringer Ingelheim Investigational Site
Thailand
- - Bangkok, Thailand
    - 1160.26.1701 Boehringer Ingelheim Investigational Site
  - Bangkok, Thailand
    - 1160.26.1702 Boehringer Ingelheim Investigational Site
  - Chiangmai, Thailand
    - 1160.26.1703 Boehringer Ingelheim Investigational Site
  - Khon Kaen, Thailand
    - 1160.26.1704 Boehringer Ingelheim Investigational Site
  - Muang Nakhonratchasima, Thailand
    - 1160.26.1705 Boehringer Ingelheim Investigational Site
Turkey
- - Adana, Turkey
    - 1160.26.1715 Boehringer Ingelheim Investigational Site
  - Ankara, Turkey
    - 1160.26.1711 Boehringer Ingelheim Investigational Site
  - Ankara, Turkey
    - 1160.26.1713 Gazi Universitesi Tip Fakultesi Kardiyoloji Abd
  - Izmir, Turkey
    - 1160.26.1714 Dokuz Eylul Universitesi Tip Fakultesi
Ukraine
- - Dnyepropetrovsk, Ukraine
    - 1160.26.1727 Boehringer Ingelheim Investigational Site
  - Kharkiv, Ukraine
    - 1160.26.1726 Boehringer Ingelheim Investigational Site
  - Kharkov, Ukraine
    - 1160.26.1724 Boehringer Ingelheim Investigational Site
  - Kharkov, Ukraine
    - 1160.26.1725 Boehringer Ingelheim Investigational Site
  - Kiev, Ukraine
    - 1160.26.1721 Boehringer Ingelheim Investigational Site
  - Kiev, Ukraine
    - 1160.26.1722 Boehringer Ingelheim Investigational Site
  - Kiev, Ukraine
    - 1160.26.1723 Boehringer Ingelheim Investigational Site
  - Kiev, Ukraine
    - 1160.26.1728 Boehringer Ingelheim Investigational Site
  - Kiev, Ukraine
    - 1160.26.1730 Boehringer Ingelheim Investigational Site
  - Kiev, Ukraine
    - 1160.26.1731 Boehringer Ingelheim Investigational Site
  - Lvov, Ukraine
    - 1160.26.1729 Boehringer Ingelheim Investigational Site
United Kingdom
- - Birmingham, United Kingdom
    - 1160.26.1744 Boehringer Ingelheim Investigational Site
  - Chertsey, United Kingdom
    - 1160.26.1746 Boehringer Ingelheim Investigational Site
  - Glasgow, United Kingdom
    - 1160.26.1747 Boehringer Ingelheim Investigational Site
  - Harrow, United Kingdom
    - 1160.26.1750 Boehringer Ingelheim Investigational Site
  - Hull, United Kingdom
    - 1160.26.1753 Boehringer Ingelheim Investigational Site
  - Kirkcaldy, Fife, United Kingdom
    - 1160.26.1755 Boehringer Ingelheim Investigational Site
  - London, United Kingdom
    - 1160.26.1741 Boehringer Ingelheim Investigational Site
  - London, United Kingdom
    - 1160.26.1756 Boehringer Ingelheim Investigational Site
  - Londonderry, United Kingdom
    - 1160.26.1749 Boehringer Ingelheim Investigational Site
  - Newcastle upon Tyne, United Kingdom
    - 1160.26.1742 Boehringer Ingelheim Investigational Site
  - Newport, United Kingdom
    - 1160.26.1751 Boehringer Ingelheim Investigational Site
  - Northampton, United Kingdom
    - 1160.26.1752 Boehringer Ingelheim Investigational Site
  - Portadown, County Atrim, United Kingdom
    - 1160.26.1745 Boehringer Ingelheim Investigational Site
  - Romford, Essex, United Kingdom
    - 1160.26.1743 Boehringer Ingelheim Investigational Site
  - Stoke-On-Trent, United Kingdom
    - 1160.26.1754 Boehringer Ingelheim Investigational Site
  - York, United Kingdom
    - 1160.26.1748 Boehringer Ingelheim Investigational Site
United States
- Alabama
  - Birmingham, Alabama, United States
    - 1160.26.0009 Boehringer Ingelheim Investigational Site
  - Birmingham, Alabama, United States
    - 1160.26.0046 Boehringer Ingelheim Investigational Site
  - Birmingham, Alabama, United States
    - 1160.26.0057 Boehringer Ingelheim Investigational Site
  - Birmingham, Alabama, United States
    - 1160.26.0211 Boehringer Ingelheim Investigational Site
  - Huntsville, Alabama, United States
    - 1160.26.0206 Boehringer Ingelheim Investigational Site
  - Mobile, Alabama, United States
    - 1160.26.0115 Boehringer Ingelheim Investigational Site
- Arizona
  - Lake Havasu City, Arizona, United States
    - 1160.26.0104 Boehringer Ingelheim Investigational Site
  - Peoria, Arizona, United States
    - 1160.26.0304 Boehringer Ingelheim Investigational Site
  - Tucson, Arizona, United States
    - 1160.26.0185 Boehringer Ingelheim Investigational Site
  - Tucson, Arizona, United States
    - 1160.26.0305 Boehringer Ingelheim Investigational Site
- Arkansas
  - Hot Springs, Arkansas, United States
    - 1160.26.0038 Boehringer Ingelheim Investigational Site
  - Jonesboro, Arkansas, United States
    - 1160.26.0302 Boehringer Ingelheim Investigational Site
  - Little Rock, Arkansas, United States
    - 1160.26.0121 Boehringer Ingelheim Investigational Site
  - Little Rock, Arkansas, United States
    - 1160.26.0191 Boehringer Ingelheim Investigational Site
  - Little Rock, Arkansas, United States
    - 1160.26.0204 Boehringer Ingelheim Investigational Site
  - Little Rock, Arkansas, United States
    - 1160.26.0213 Boehringer Ingelheim Investigational Site
  - Little Rock, Arkansas, United States
    - 1160.26.0455 Boehringer Ingelheim Investigational Site
- California
  - Anaheim, California, United States
    - 1160.26.0388 Boehringer Ingelheim Investigational Site
  - Carmichael, California, United States
    - 1160.26.0441 Boehringer Ingelheim Investigational Site
  - French Camp, California, United States
    - 1160.26.0145 Boehringer Ingelheim Investigational Site
  - Fullerton, California, United States
    - 1160.26.0333 Boehringer Ingelheim Investigational Site
  - La Jolla, California, United States
    - 1160.26.0384 Boehringer Ingelheim Investigational Site
  - La Mesa, California, United States
    - 1160.26.0091 Boehringer Ingelheim Investigational Site
  - Lancaster, California, United States
    - 1160.26.0246 Boehringer Ingelheim Investigational Site
  - Larkspur, California, United States
    - 1160.26.0345 Boehringer Ingelheim Investigational Site
  - Loma Linda, California, United States
    - 1160.26.0217 Boehringer Ingelheim Investigational Site
  - Los Angeles, California, United States
    - 1160.26.0059 Boehringer Ingelheim Investigational Site
  - Los Angeles, California, United States
    - 1160.26.0088 Boehringer Ingelheim Investigational Site
  - Los Angeles, California, United States
    - 1160.26.0337 Boehringer Ingelheim Investigational Site
  - Mather, California, United States
    - 1160.26.0326 Boehringer Ingelheim Investigational Site
  - Merced, California, United States
    - 1160.26.0070 Boehringer Ingelheim Investigational Site
  - Oakland, California, United States
    - 1160.26.0349 Boehringer Ingelheim Investigational Site
  - Oceanside, California, United States
    - 1160.26.0016 Boehringer Ingelheim Investigational Site
  - Palm Springs, California, United States
    - 1160.26.0087 Boehringer Ingelheim Investigational Site
  - Pasadena, California, United States
    - 1160.26.0459 Boehringer Ingelheim Investigational Site
  - Redondo Beach, California, United States
    - 1160.26.0216 Boehringer Ingelheim Investigational Site
  - Riverside, California, United States
    - 1160.26.0135 Boehringer Ingelheim Investigational Site
  - Sacramento, California, United States
    - 1160.26.0162 Boehringer Ingelheim Investigational Site
  - Sacramento, California, United States
    - 1160.26.0300 Boehringer Ingelheim Investigational Site
  - Sacramento, California, United States
    - 1160.26.0371 Boehringer Ingelheim Investigational Site
  - San Diego, California, United States
    - 1160.26.0116 Boehringer Ingelheim Investigational Site
  - San Diego, California, United States
    - 1160.26.0148 Boehringer Ingelheim Investigational Site
  - San Diego, California, United States
    - 1160.26.0270 Boehringer Ingelheim Investigational Site
  - San Diego, California, United States
    - 1160.26.0284 Boehringer Ingelheim Investigational Site
  - Santa Ana, California, United States
    - 1160.26.0351 Boehringer Ingelheim Investigational Site
  - Santa Rosa, California, United States
    - 1160.26.0043 Boehringer Ingelheim Investigational Site
  - Sylmar, California, United States
    - 1160.26.0462 Boehringer Ingelheim Investigational Site
  - Torrance, California, United States
    - 1160.26.0276 Boehringer Ingelheim Investigational Site
  - Walnut Creek, California, United States
    - 1160.26.0379 Boehringer Ingelheim Investigational Site
- Colorado
  - Aurora, Colorado, United States
    - 1160.26.0419 Boehringer Ingelheim Investigational Site
  - Colorado Springs, Colorado, United States
    - 1160.26.0321 Boehringer Ingelheim Investigational Site
  - Colorado Springs, Colorado, United States
    - 1160.26.0449 Boehringer Ingelheim Investigational Site
  - Denver, Colorado, United States
    - 1160.26.0360 Boehringer Ingelheim Investigational Site
  - Denver, Colorado, United States
    - 1160.26.0413 Boehringer Ingelheim Investigational Site
  - Fort Collins, Colorado, United States
    - 1160.26.0362 Boehringer Ingelheim Investigational Site
  - Greeley, Colorado, United States
    - 1160.26.0399 Boehringer Ingelheim Investigational Site
- Connecticut
  - Bridgeport, Connecticut, United States
    - 1160.26.0058 Boehringer Ingelheim Investigational Site
  - Bridgeport, Connecticut, United States
    - 1160.26.0241 Boehringer Ingelheim Investigational Site
  - Bridgeport, Connecticut, United States
    - 1160.26.0278 Boehringer Ingelheim Investigational Site
  - Fairfield, Connecticut, United States
    - 1160.26.0085 Boehringer Ingelheim Investigational Site
  - Guilford, Connecticut, United States
    - 1160.26.0482 Boehringer Ingelheim Investigational Site
- Delaware
  - Newark, Delaware, United States
    - 1160.26.0366 Boehringer Ingelheim Investigational Site
- District of Columbia
  - Washington, District of Columbia, United States
    - 1160.26.0343 Boehringer Ingelheim Investigational Site
- Florida
  - Atlantis, Florida, United States
    - 1160.26.0022 Boehringer Ingelheim Investigational Site
  - Boynton Beach, Florida, United States
    - 1160.26.0382 Boehringer Ingelheim Investigational Site
  - Brandon, Florida, United States
    - 1160.26.0056 Boehringer Ingelheim Investigational Site
  - Clearwater, Florida, United States
    - 1160.26.0105 Boehringer Ingelheim Investigational Site
  - Clearwater, Florida, United States
    - 1160.26.0296 Boehringer Ingelheim Investigational Site
  - Clearwater, Florida, United States
    - 1160.26.0429 Boehringer Ingelheim Investigational Site
  - Daytona Beach, Florida, United States
    - 1160.26.0376 Boehringer Ingelheim Investigational Site
  - Deerfield Beach, Florida, United States
    - 1160.26.0411 Boehringer Ingelheim Investigational Site
  - Fort Myers, Florida, United States
    - 1160.26.0074 Boehringer Ingelheim Investigational Site
  - Gainesville, Florida, United States
    - 1160.26.0239 Boehringer Ingelheim Investigational Site
  - Hollywood, Florida, United States
    - 1160.26.0260 Boehringer Ingelheim Investigational Site
  - Hollywood, Florida, United States
    - 1160.26.0265 Boehringer Ingelheim Investigational Site
  - Inverness, Florida, United States
    - 1160.26.0100 Boehringer Ingelheim Investigational Site
  - Jacksonville, Florida, United States
    - 1160.26.0033 Boehringer Ingelheim Investigational Site
  - Jacksonville, Florida, United States
    - 1160.26.0089 Boehringer Ingelheim Investigational Site
  - Jacksonville, Florida, United States
    - 1160.26.0232 Boehringer Ingelheim Investigational Site
  - Jacksonville, Florida, United States
    - 1160.26.0240 Boehringer Ingelheim Investigational Site
  - Jacksonville, Florida, United States
    - 1160.26.0427 Boehringer Ingelheim Investigational Site
  - Jacksonville, Florida, United States
    - 1160.26.0464 Boehringer Ingelheim Investigational Site
  - Jacksonville Beach, Florida, United States
    - 1160.26.0209 Boehringer Ingelheim Investigational Site
  - Lakeland, Florida, United States
    - 1160.26.0012 Boehringer Ingelheim Investigational Site
  - Melbourne, Florida, United States
    - 1160.26.0259 Boehringer Ingelheim Investigational Site
  - Melbourne, Florida, United States
    - 1160.26.0358 Boehringer Ingelheim Investigational Site
  - Miami, Florida, United States
    - 1160.26.0034 Boehringer Ingelheim Investigational Site
  - Miami, Florida, United States
    - 1160.26.0199 Boehringer Ingelheim Investigational Site
  - Orlando, Florida, United States
    - 1160.26.0227 Boehringer Ingelheim Investigational Site
  - Ormond Beach, Florida, United States
    - 1160.26.0095 Boehringer Ingelheim Investigational Site
  - Pensacola, Florida, United States
    - 1160.26.0037 Boehringer Ingelheim Investigational Site
  - Pensacola, Florida, United States
    - 1160.26.0076 Boehringer Ingelheim Investigational Site
  - Pensacola, Florida, United States
    - 1160.26.0081 Boehringer Ingelheim Investigational Site
  - Pensacola, Florida, United States
    - 1160.26.0111 Boehringer Ingelheim Investigational Site
  - Port Charlotte, Florida, United States
    - 1160.26.0137 Boehringer Ingelheim Investigational Site
  - Port Charlotte, Florida, United States
    - 1160.26.0389 Boehringer Ingelheim Investigational Site
  - Port Charlotte, Florida, United States
    - 1160.26.0417 Boehringer Ingelheim Investigational Site
  - Rockledge, Florida, United States
    - 1160.26.0332 Boehringer Ingelheim Investigational Site
  - Safety Harbor, Florida, United States
    - 1160.26.0226 Boehringer Ingelheim Investigational Site
  - Saint Petersburg, Florida, United States
    - 1160.26.0015 Boehringer Ingelheim Investigational Site
  - Saint Petersburg, Florida, United States
    - 1160.26.0339 Boehringer Ingelheim Investigational Site
  - Sarasota, Florida, United States
    - 1160.26.0031 Boehringer Ingelheim Investigational Site
  - Sarasota, Florida, United States
    - 1160.26.0385 Boehringer Ingelheim Investigational Site
  - Stuart, Florida, United States
    - 1160.26.0010 Boehringer Ingelheim Investigational Site
  - Tamarac, Florida, United States
    - 1160.26.0327 Boehringer Ingelheim Investigational Site
  - Tampa, Florida, United States
    - 1160.26.0271 Boehringer Ingelheim Investigational Site
  - Tampa, Florida, United States
    - 1160.26.0328 Boehringer Ingelheim Investigational Site
  - Tampa, Florida, United States
    - 1160.26.0381 Boehringer Ingelheim Investigational Site
  - Vero Beach, Florida, United States
    - 1160.26.0019 Boehringer Ingelheim Investigational Site
- Georgia
  - Atlanta, Georgia, United States
    - 1160.26.0159 Boehringer Ingelheim Investigational Site
  - Atlanta, Georgia, United States
    - 1160.26.0283 Boehringer Ingelheim Investigational Site
  - Atlanta, Georgia, United States
    - 1160.26.0338 Boehringer Ingelheim Investigational Site
  - Augusta, Georgia, United States
    - 1160.26.0021 Boehringer Ingelheim Investigational Site
  - Augusta, Georgia, United States
    - 1160.26.0319 Boehringer Ingelheim Investigational Site
  - Blue Ridge, Georgia, United States
    - 1160.26.0092 Boehringer Ingelheim Investigational Site
  - Conyers, Georgia, United States
    - 1160.26.0161 Boehringer Ingelheim Investigational Site
- Idaho
  - Coeur d'Alene, Idaho, United States
    - 1160.26.0026 Boehringer Ingelheim Investigational Site
- Illinois
  - Berwyn, Illinois, United States
    - 1160.26.0218 Boehringer Ingelheim Investigational Site
  - Chicago, Illinois, United States
    - 1160.26.0184 Boehringer Ingelheim Investigational Site
  - Chicago, Illinois, United States
    - 1160.26.0233 Boehringer Ingelheim Investigational Site
  - Chicago, Illinois, United States
    - 1160.26.0324 Boehringer Ingelheim Investigational Site
  - Chicago, Illinois, United States
    - 1160.26.0457 Boehringer Ingelheim Investigational Site
  - Evanston, Illinois, United States
    - 1160.26.0237 Boehringer Ingelheim Investigational Site
  - Glenview, Illinois, United States
    - 1160.26.0236 Boehringer Ingelheim Investigational Site
  - Hines, Illinois, United States
    - 1160.26.0396 Boehringer Ingelheim Investigational Site
  - Maywood, Illinois, United States
    - 1160.26.0438 Boehringer Ingelheim Investigational Site
  - Melrose Park, Illinois, United States
    - 1160.26.0331 Boehringer Ingelheim Investigational Site
  - Normal, Illinois, United States
    - 1160.26.0364 Boehringer Ingelheim Investigational Site
  - North Chicago, Illinois, United States
    - 1160.26.0109 Boehringer Ingelheim Investigational Site
  - Oak Lawn, Illinois, United States
    - 1160.26.0152 Boehringer Ingelheim Investigational Site
  - Rockford, Illinois, United States
    - 1160.26.0198 Boehringer Ingelheim Investigational Site
  - Winfield, Illinois, United States
    - 1160.26.0433 Boehringer Ingelheim Investigational Site
- Indiana
  - Evansville, Indiana, United States
    - 1160.26.0041 Boehringer Ingelheim Investigational Site
  - Fort Wayne, Indiana, United States
    - 1160.26.0377 Boehringer Ingelheim Investigational Site
  - Indianapolis, Indiana, United States
    - 1160.26.0288 Boehringer Ingelheim Investigational Site
  - Indianapolis, Indiana, United States
    - 1160.26.0352 Boehringer Ingelheim Investigational Site
  - Indianapolis, Indiana, United States
    - 1160.26.0436 Boehringer Ingelheim Investigational Site
  - Jeffersonville, Indiana, United States
    - 1160.26.0028 Boehringer Ingelheim Investigational Site
  - South Bend, Indiana, United States
    - 1160.26.0235 Boehringer Ingelheim Investigational Site
- Iowa
  - Dubuque, Iowa, United States
    - 1160.26.0268 Boehringer Ingelheim Investigational Site
  - West Des Moines, Iowa, United States
    - 1160.26.0001 Boehringer Ingelheim Investigational Site
  - West Des Moines, Iowa, United States
    - 1160.26.0189 Boehringer Ingelheim Investigational Site
  - West Des Moines, Iowa, United States
    - 1160.26.0357 Boehringer Ingelheim Investigational Site
- Kansas
  - Wichita, Kansas, United States
    - 1160.26.0354 Boehringer Ingelheim Investigational Site
- Kentucky
  - Bowling Green, Kentucky, United States
    - 1160.26.0077 Boehringer Ingelheim Investigational Site
  - Crestview Hills, Kentucky, United States
    - 1160.26.0138 Boehringer Ingelheim Investigational Site
  - Lexington, Kentucky, United States
    - 1160.26.0422 Boehringer Ingelheim Investigational Site
  - Louisville, Kentucky, United States
    - 1160.26.0178 Boehringer Ingelheim Investigational Site
  - Louisville, Kentucky, United States
    - 1160.26.0397 Boehringer Ingelheim Investigational Site
  - Owensboro, Kentucky, United States
    - 1160.26.0310 Boehringer Ingelheim Investigational Site
- Louisiana
  - Baton Rouge, Louisiana, United States
    - 1160.26.0011 Boehringer Ingelheim Investigational Site
  - Baton Rouge, Louisiana, United States
    - 1160.26.0144 Boehringer Ingelheim Investigational Site
  - Baton Rouge, Louisiana, United States
    - 1160.26.0404 Boehringer Ingelheim Investigational Site
  - Covington, Louisiana, United States
    - 1160.26.0093 Boehringer Ingelheim Investigational Site
  - Lacombe, Louisiana, United States
    - 1160.26.0340 Boehringer Ingelheim Investigational Site
  - Lafayette, Louisiana, United States
    - 1160.26.0018 Boehringer Ingelheim Investigational Site
  - Lafayette, Louisiana, United States
    - 1160.26.0391 Boehringer Ingelheim Investigational Site
  - Morgan City, Louisiana, United States
    - 1160.26.0252 Boehringer Ingelheim Investigational Site
  - New Iberia, Louisiana, United States
    - 1160.26.0132 Boehringer Ingelheim Investigational Site
  - New Orleans, Louisiana, United States
    - 1160.26.0299 Tulane University School Of Medicine
  - Shreveport, Louisiana, United States
    - 1160.26.0048 Boehringer Ingelheim Investigational Site
- Maine
  - Auburn, Maine, United States
    - 1160.26.0096 Boehringer Ingelheim Investigational Site
  - Scarborough, Maine, United States
    - 1160.26.0068 Boehringer Ingelheim Investigational Site
- Maryland
  - Annapolis, Maryland, United States
    - 1160.26.0114 Boehringer Ingelheim Investigational Site
  - Annapolis, Maryland, United States
    - 1160.26.0164 Boehringer Ingelheim Investigational Site
  - Baltimore, Maryland, United States
    - 1160.26.0023 Boehringer Ingelheim Investigational Site
  - Baltimore, Maryland, United States
    - 1160.26.0047 Boehringer Ingelheim Investigational Site
  - Baltimore, Maryland, United States
    - 1160.26.0079 Boehringer Ingelheim Investigational Site
  - Baltimore, Maryland, United States
    - 1160.26.0186 Boehringer Ingelheim Investigational Site
  - Baltimore, Maryland, United States
    - 1160.26.0194 Boehringer Ingelheim Investigational Site
  - Bel Air, Maryland, United States
    - 1160.26.0255 Boehringer Ingelheim Investigational Site
  - Columbia, Maryland, United States
    - 1160.26.0398 Boehringer Ingelheim Investigational Site
  - Rockville, Maryland, United States
    - 1160.26.0177 Boehringer Ingelheim Investigational Site
  - Salisbury, Maryland, United States
    - 1160.26.0073 Boehringer Ingelheim Investigational Site
  - Salisbury, Maryland, United States
    - 1160.26.0207 Boehringer Ingelheim Investigational Site
  - Takoma Park, Maryland, United States
    - 1160.26.0196 Boehringer Ingelheim Investigational Site
  - Towson, Maryland, United States
    - 1160.26.0187 Boehringer Ingelheim Investigational Site
  - Westminster, Maryland, United States
    - 1160.26.0052 Boehringer Ingelheim Investigational Site
- Massachusetts
  - Ayer, Massachusetts, United States
    - 1160.26.0042 Boehringer Ingelheim Investigational Site
  - Boston, Massachusetts, United States
    - 1160.26.0401 Boehringer Ingelheim Investigational Site
  - East Bridgewater, Massachusetts, United States
    - 1160.26.0160 Boehringer Ingelheim Investigational Site
  - Haverhill, Massachusetts, United States
    - 1160.26.0443 Boehringer Ingelheim Investigational Site
  - Haverhill, Massachusetts, United States
    - 1160.26.0452 Boehringer Ingelheim Investigational Site
  - Natick, Massachusetts, United States
    - 1160.26.0029 Boehringer Ingelheim Investigational Site
  - Newtown, Massachusetts, United States
    - 1160.26.0446 Boehringer Ingelheim Investigational Site
  - North Dartmouth, Massachusetts, United States
    - 1160.26.0003 Boehringer Ingelheim Investigational Site
  - Northborough, Massachusetts, United States
    - 1160.26.0470 Boehringer Ingelheim Investigational Site
  - Worcester, Massachusetts, United States
    - 1160.26.0308 Boehringer Ingelheim Investigational Site
- Michigan
  - Bloomfield Hills, Michigan, United States
    - 1160.26.0141 Boehringer Ingelheim Investigational Site
  - Detroit, Michigan, United States
    - 1160.26.0225 Boehringer Ingelheim Investigational Site
  - Grand Blanc, Michigan, United States
    - 1160.26.0154 Boehringer Ingelheim Investigational Site
  - Grand Rapids, Michigan, United States
    - 1160.26.0030 Boehringer Ingelheim Investigational Site
  - Kalamazoo, Michigan, United States
    - 1160.26.0171 Boehringer Ingelheim Investigational Site
  - Lapeer, Michigan, United States
    - 1160.26.0205 Boehringer Ingelheim Investigational Site
  - Muskegon, Michigan, United States
    - 1160.26.0279 Boehringer Ingelheim Investigational Site
  - Petoskey, Michigan, United States
    - 1160.26.0445 Boehringer Ingelheim Investigational Site
  - Rochester Hills, Michigan, United States
    - 1160.26.0274 Boehringer Ingelheim Investigational Site
  - Saginaw, Michigan, United States
    - 1160.26.0165 Boehringer Ingelheim Investigational Site
  - Troy, Michigan, United States
    - 1160.26.0020 Boehringer Ingelheim Investigational Site
  - Ypsilanti, Michigan, United States
    - 1160.26.0188 Boehringer Ingelheim Investigational Site
- Minnesota
  - Minneapolis, Minnesota, United States
    - 1160.26.0131 Boehringer Ingelheim Investigational Site
  - Minneapolis, Minnesota, United States
    - 1160.26.0421 Boehringer Ingelheim Investigational Site
  - Robbinsdale, Minnesota, United States
    - 1160.26.0202 Boehringer Ingelheim Investigational Site
  - Saint Paul, Minnesota, United States
    - 1160.26.0101 Boehringer Ingelheim Investigational Site
- Mississippi
  - Gulfport, Mississippi, United States
    - 1160.26.0086 Boehringer Ingelheim Investigational Site
  - Tupelo, Mississippi, United States
    - 1160.26.0119 Boehringer Ingelheim Investigational Site
- Missouri
  - Columbia, Missouri, United States
    - 1160.26.0055 Boehringer Ingelheim Investigational Site
  - Columbia, Missouri, United States
    - 1160.26.0172 Boehringer Ingelheim Investigational Site
  - Kansas City, Missouri, United States
    - 1160.26.0257 Boehringer Ingelheim Investigational Site
  - Kansas City, Missouri, United States
    - 1160.26.0266 Boehringer Ingelheim Investigational Site
  - Saint Charles, Missouri, United States
    - 1160.26.0336 Boehringer Ingelheim Investigational Site
  - Saint Louis, Missouri, United States
    - 1160.26.0249 Boehringer Ingelheim Investigational Site
- Montana
  - Kalispell, Montana, United States
    - 1160.26.0027 Boehringer Ingelheim Investigational Site
- Nebraska
  - Alliance, Nebraska, United States
    - 1160.26.0128 Boehringer Ingelheim Investigational Site
  - Omaha, Nebraska, United States
    - 1160.26.0110 Boehringer Ingelheim Investigational Site
  - Papillion, Nebraska, United States
    - 1160.26.0355 Boehringer Ingelheim Investigational Site
- Nevada
  - Henderson, Nevada, United States
    - 1160.26.0346 Boehringer Ingelheim Investigational Site
  - Las Vegas, Nevada, United States
    - 1160.26.0066 Boehringer Ingelheim Investigational Site
  - Las Vegas, Nevada, United States
    - 1160.26.0174 Boehringer Ingelheim Investigational Site
  - Las Vegas, Nevada, United States
    - 1160.26.0430 Boehringer Ingelheim Investigational Site
- New Hampshire
  - Lebanon, New Hampshire, United States
    - 1160.26.0190 Boehringer Ingelheim Investigational Site
- New Jersey
  - Browns Mills, New Jersey, United States
    - 1160.26.0142 Boehringer Ingelheim Investigational Site
  - Cherry Hill, New Jersey, United States
    - 1160.26.0125 Boehringer Ingelheim Investigational Site
  - Elmer, New Jersey, United States
    - 1160.26.0432 Boehringer Ingelheim Investigational Site
  - Englewood, New Jersey, United States
    - 1160.26.0448 Boehringer Ingelheim Investigational Site
  - Flemington, New Jersey, United States
    - 1160.26.0248 Boehringer Ingelheim Investigational Site
  - Haddon Heights, New Jersey, United States
    - 1160.26.0244 Boehringer Ingelheim Investigational Site
  - New Brunswick, New Jersey, United States
    - 1160.26.0243 Boehringer Ingelheim Investigational Site
  - Oakland, New Jersey, United States
    - 1160.26.0478 Boehringer Ingelheim Investigational Site
  - Ocean City, New Jersey, United States
    - 1160.26.0392 Boehringer Ingelheim Investigational Site
  - Paterson, New Jersey, United States
    - 1160.26.0472 Boehringer Ingelheim Investigational Site
  - Voorhees, New Jersey, United States
    - 1160.26.0221 Boehringer Ingelheim Investigational Site
  - Westwood, New Jersey, United States
    - 1160.26.0254 Boehringer Ingelheim Investigational Site
- New Mexico
  - Albuquerque, New Mexico, United States
    - 1160.26.0127 Boehringer Ingelheim Investigational Site
  - Albuquerque, New Mexico, United States
    - 1160.26.0423 Boehringer Ingelheim Investigational Site
- New York
  - Albany, New York, United States
    - 1160.26.0476 Boehringer Ingelheim Investigational Site
  - Bronx, New York, United States
    - 1160.26.0113 Boehringer Ingelheim Investigational Site
  - Bronx, New York, United States
    - 1160.26.0281 Boehringer Ingelheim Investigational Site
  - Buffalo, New York, United States
    - 1160.26.0063 Boehringer Ingelheim Investigational Site
  - Cortlandt Manor, New York, United States
    - 1160.26.0044 Boehringer Ingelheim Investigational Site
  - Flushing, New York, United States
    - 1160.26.0373 Boehringer Ingelheim Investigational Site
  - Garden City, New York, United States
    - 1160.26.0045 Boehringer Ingelheim Investigational Site
  - Kingston, New York, United States
    - 1160.26.0251 Boehringer Ingelheim Investigational Site
  - Mineola, New York, United States
    - 1160.26.0229 Boehringer Ingelheim Investigational Site
  - Mineola, New York, United States
    - 1160.26.0451 Boehringer Ingelheim Investigational Site
  - New Hyde Park, New York, United States
    - 1160.26.0090 Boehringer Ingelheim Investigational Site
  - New Rochelle, New York, United States
    - 1160.26.0183 Boehringer Ingelheim Investigational Site
  - New York, New York, United States
    - 1160.26.0316 Boehringer Ingelheim Investigational Site
  - North Massapequa, New York, United States
    - 1160.26.0146 Boehringer Ingelheim Investigational Site
  - Northport, New York, United States
    - 1160.26.0210 Boehringer Ingelheim Investigational Site
  - Poughkeepsie, New York, United States
    - 1160.26.0075 Boehringer Ingelheim Investigational Site
  - Rochester, New York, United States
    - 1160.26.0197 Boehringer Ingelheim Investigational Site
  - Rochester, New York, United States
    - 1160.26.0320 Boehringer Ingelheim Investigational Site
  - Scarsdale, New York, United States
    - 1160.26.0064 Boehringer Ingelheim Investigational Site
  - Troy, New York, United States
    - 1160.26.0414 Boehringer Ingelheim Investigational Site
  - Watertown, New York, United States
    - 1160.26.0356 Boehringer Ingelheim Investigational Site
  - Williamsville, New York, United States
    - 1160.26.0039 Boehringer Ingelheim Investigational Site
- North Carolina
  - Asheville, North Carolina, United States
    - 1160.26.0353 Boehringer Ingelheim Investigational Site
  - Charlotte, North Carolina, United States
    - 1160.26.0080 Boehringer Ingelheim Investigational Site
  - Charlotte, North Carolina, United States
    - 1160.26.0412 Boehringer Ingelheim Investigational Site
  - Gastonia, North Carolina, United States
    - 1160.26.0350 Boehringer Ingelheim Investigational Site
  - Greensboro, North Carolina, United States
    - 1160.26.0322 Boehringer Ingelheim Investigational Site
  - High Point, North Carolina, United States
    - 1160.26.0173 Boehringer Ingelheim Investigational Site
  - Lexington, North Carolina, United States
    - 1160.26.0108 Boehringer Ingelheim Investigational Site
  - Pinehurst, North Carolina, United States
    - 1160.26.0006 Boehringer Ingelheim Investigational Site
  - Statesville, North Carolina, United States
    - 1160.26.0002 Boehringer Ingelheim Investigational Site
  - Statesville, North Carolina, United States
    - 1160.26.0069 Boehringer Ingelheim Investigational Site
  - Wilmington, North Carolina, United States
    - 1160.26.0372 Boehringer Ingelheim Investigational Site
  - Winston-Salem, North Carolina, United States
    - 1160.26.0094 Boehringer Ingelheim Investigational Site
  - Winston-Salem, North Carolina, United States
    - 1160.26.0425 Boehringer Ingelheim Investigational Site
- North Dakota
  - Grand Forks, North Dakota, United States
    - 1160.26.0102 Boehringer Ingelheim Investigational Site
  - Jamestown, North Dakota, United States
    - 1160.26.0222 Boehringer Ingelheim Investigational Site
- Ohio
  - Akron, Ohio, United States
    - 1160.26.0203 Boehringer Ingelheim Investigational Site
  - Canal Fulton, Ohio, United States
    - 1160.26.0434 Boehringer Ingelheim Investigational Site
  - Cincinnati, Ohio, United States
    - 1160.26.0083 Boehringer Ingelheim Investigational Site
  - Cincinnati, Ohio, United States
    - 1160.26.0402 Boehringer Ingelheim Investigational Site
  - Cincinnati, Ohio, United States
    - 1160.26.0426 Boehringer Ingelheim Investigational Site
  - Cincinnati, Ohio, United States
    - 1160.26.0479 Boehringer Ingelheim Investigational Site
  - Cleveland, Ohio, United States
    - 1160.26.0263 Boehringer Ingelheim Investigational Site
  - Cleveland, Ohio, United States
    - 1160.26.0480 Boehringer Ingelheim Investigational Site
  - Columbus, Ohio, United States
    - 1160.26.0267 Boehringer Ingelheim Investigational Site
  - Dayton, Ohio, United States
    - 1160.26.0035 Boehringer Ingelheim Investigational Site
  - Fairview Park, Ohio, United States
    - 1160.26.0150 Boehringer Ingelheim Investigational Site
  - Kettering, Ohio, United States
    - 1160.26.0201 Boehringer Ingelheim Investigational Site
  - Lorain, Ohio, United States
    - 1160.26.0223 Boehringer Ingelheim Investigational Site
  - Lyndhurst, Ohio, United States
    - 1160.26.0214 Boehringer Ingelheim Investigational Site
  - Sandusky, Ohio, United States
    - 1160.26.0275 Boehringer Ingelheim Investigational Site
  - Westlake, Ohio, United States
    - 1160.26.0103 Boehringer Ingelheim Investigational Site
- Oklahoma
  - Bartlesville, Oklahoma, United States
    - 1160.26.0155 Boehringer Ingelheim Investigational Site
  - Tulsa, Oklahoma, United States
    - 1160.26.0435 Boehringer Ingelheim Investigational Site
- Oregon
  - Corvallis, Oregon, United States
    - 1160.26.0139 Boehringer Ingelheim Investigational Site
  - Eugene, Oregon, United States
    - 1160.26.0325 Boehringer Ingelheim Investigational Site
  - Hillsboro, Oregon, United States
    - 1160.26.0078 Boehringer Ingelheim Investigational Site
  - Portland, Oregon, United States
    - 1160.26.0245 Boehringer Ingelheim Investigational Site
  - Springfield, Oregon, United States
    - 1160.26.0133 Boehringer Ingelheim Investigational Site
- Pennsylvania
  - Allentown, Pennsylvania, United States
    - 1160.26.0301 Boehringer Ingelheim Investigational Site
  - Altoona, Pennsylvania, United States
    - 1160.26.0454 Boehringer Ingelheim Investigational Site
  - Camp Hill, Pennsylvania, United States
    - 1160.26.0295 Boehringer Ingelheim Investigational Site
  - Hershey, Pennsylvania, United States
    - 1160.26.0294 Boehringer Ingelheim Investigational Site
  - Jenkintown, Pennsylvania, United States
    - 1160.26.0369 Boehringer Ingelheim Investigational Site
  - Jersey Shore, Pennsylvania, United States
    - 1160.26.0303 Boehringer Ingelheim Investigational Site
  - Lancaster, Pennsylvania, United States
    - 1160.26.0431 Boehringer Ingelheim Investigational Site
  - Langhorne, Pennsylvania, United States
    - 1160.26.0168 Boehringer Ingelheim Investigational Site
  - Meadowbrook, Pennsylvania, United States
    - 1160.26.0293 Boehringer Ingelheim Investigational Site
  - Newton, Pennsylvania, United States
    - 1160.26.0025 Boehringer Ingelheim Investigational Site
  - Norristown, Pennsylvania, United States
    - 1160.26.0394 Boehringer Ingelheim Investigational Site
  - Philadelphia, Pennsylvania, United States
    - 1160.26.0158 Boehringer Ingelheim Investigational Site
  - Philadelphia, Pennsylvania, United States
    - 1160.26.0181 Boehringer Ingelheim Investigational Site
  - Philadelphia, Pennsylvania, United States
    - 1160.26.0416 Boehringer Ingelheim Investigational Site
  - Pittsburgh, Pennsylvania, United States
    - 1160.26.0344 Boehringer Ingelheim Investigational Site
  - Pittsburgh, Pennsylvania, United States
    - 1160.26.0466 Boehringer Ingelheim Investigational Site
  - Sellersville, Pennsylvania, United States
    - 1160.26.0208 Boehringer Ingelheim Investigational Site
  - Uniontown, Pennsylvania, United States
    - 1160.26.0465 Boehringer Ingelheim Investigational Site
  - Upland, Pennsylvania, United States
    - 1160.26.0400 Boehringer Ingelheim Investigational Site
  - Wynnewood, Pennsylvania, United States
    - 1160.26.0032 Boehringer Ingelheim Investigational Site
  - Wyomissing, Pennsylvania, United States
    - 1160.26.0067 Boehringer Ingelheim Investigational Site
- Rhode Island
  - Pawtucket, Rhode Island, United States
    - 1160.26.0212 Boehringer Ingelheim Investigational Site
- South Carolina
  - Beaufort, South Carolina, United States
    - 1160.26.0007 Boehringer Ingelheim Investigational Site
  - Charleston, South Carolina, United States
    - 1160.26.0383 Boehringer Ingelheim Investigational Site
  - Greenville, South Carolina, United States
    - 1160.26.0313 Boehringer Ingelheim Investigational Site
  - Mount Pleasant, South Carolina, United States
    - 1160.26.0450 Boehringer Ingelheim Investigational Site
  - Spartanburg, South Carolina, United States
    - 1160.26.0166 Boehringer Ingelheim Investigational Site
  - Summerville, South Carolina, United States
    - 1160.26.0008 Boehringer Ingelheim Investigational Site
  - West Columbia, South Carolina, United States
    - 1160.26.0468 Boehringer Ingelheim Investigational Site
- South Dakota
  - Rapid City, South Dakota, United States
    - 1160.26.0348 Boehringer Ingelheim Investigational Site
- Tennessee
  - Chattanooga, Tennessee, United States
    - 1160.26.0084 Boehringer Ingelheim Investigational Site
  - Germantown, Tennessee, United States
    - 1160.26.0062 Boehringer Ingelheim Investigational Site
  - Johnson City, Tennessee, United States
    - 1160.26.0370 Boehringer Ingelheim Investigational Site
  - Nashville, Tennessee, United States
    - 1160.26.0323 Boehringer Ingelheim Investigational Site
  - Nashville, Tennessee, United States
    - 1160.26.0395 Boehringer Ingelheim Investigational Site
  - Oak Ridge, Tennessee, United States
    - 1160.26.0474 Boehringer Ingelheim Investigational Site
- Texas
  - Austin, Texas, United States
    - 1160.26.0129 Boehringer Ingelheim Investigational Site
  - Austin, Texas, United States
    - 1160.26.0410 Boehringer Ingelheim Investigational Site
  - Dallas, Texas, United States
    - 1160.26.0156 Boehringer Ingelheim Investigational Site
  - Fort Worth, Texas, United States
    - 1160.26.0315 Boehringer Ingelheim Investigational Site
  - Fort Worth, Texas, United States
    - 1160.26.0444 Boehringer Ingelheim Investigational Site
  - Houston, Texas, United States
    - 1160.26.0447 Boehringer Ingelheim Investigational Site
  - Killeen, Texas, United States
    - 1160.26.0483 Boehringer Ingelheim Investigational Site
  - Lubbock, Texas, United States
    - 1160.26.0335 Boehringer Ingelheim Investigational Site
  - McKinney, Texas, United States
    - 1160.26.0230 Boehringer Ingelheim Investigational Site
  - Plano, Texas, United States
    - 1160.26.0467 Boehringer Ingelheim Investigational Site
  - San Antonio, Texas, United States
    - 1160.26.0013 Boehringer Ingelheim Investigational Site
  - San Antonio, Texas, United States
    - 1160.26.0269 Boehringer Ingelheim Investigational Site
  - San Antonio, Texas, United States
    - 1160.26.0307 Boehringer Ingelheim Investigational Site
  - San Marcos, Texas, United States
    - 1160.26.0285 Boehringer Ingelheim Investigational Site
  - Tyler, Texas, United States
    - 1160.26.0215 Boehringer Ingelheim Investigational Site
  - Tyler, Texas, United States
    - 1160.26.0367 Boehringer Ingelheim Investigational Site
- Virginia
  - Arlington, Virginia, United States
    - 1160.26.0195 Boehringer Ingelheim Investigational Site
  - Charlottesville, Virginia, United States
    - 1160.26.0453 Boehringer Ingelheim Investigational Site
  - Chesapeake, Virginia, United States
    - 1160.26.0053 Boehringer Ingelheim Investigational Site
  - Danville, Virginia, United States
    - 1160.26.0098 Boehringer Ingelheim Investigational Site
  - Falls Church, Virginia, United States
    - 1160.26.0386 Boehringer Ingelheim Investigational Site
  - Fredericksburg, Virginia, United States
    - 1160.26.0428 Boehringer Ingelheim Investigational Site
  - Harrisonburg, Virginia, United States
    - 1160.26.0311 Boehringer Ingelheim Investigational Site
  - Newport News, Virginia, United States
    - 1160.26.0292 Boehringer Ingelheim Investigational Site
  - Norfolk, Virginia, United States
    - 1160.26.0224 Boehringer Ingelheim Investigational Site
  - Salem, Virginia, United States
    - 1160.26.0220 Boehringer Ingelheim Investigational Site
  - Winchester, Virginia, United States
    - 1160.26.0317 Boehringer Ingelheim Investigational Site
- Washington
  - Bellevue, Washington, United States
    - 1160.26.0287 Boehringer Ingelheim Investigational Site
  - Bellingham, Washington, United States
    - 1160.26.0050 Boehringer Ingelheim Investigational Site
  - Burien, Washington, United States
    - 1160.26.0040 Boehringer Ingelheim Investigational Site
  - Olympia, Washington, United States
    - 1160.26.0298 Boehringer Ingelheim Investigational Site
  - Spokane, Washington, United States
    - 1160.26.0250 Boehringer Ingelheim Investigational Site
  - Tacoma, Washington, United States
    - 1160.26.0256 Boehringer Ingelheim Investigational Site
  - Wenatchee, Washington, United States
    - 1160.26.0024 Boehringer Ingelheim Investigational Site
- West Virginia
  - Charleston, West Virginia, United States
    - 1160.26.0193 Boehringer Ingelheim Investigational Site
  - Clarksburg, West Virginia, United States
    - 1160.26.0169 Boehringer Ingelheim Investigational Site
  - Huntington, West Virginia, United States
    - 1160.26.0365 Boehringer Ingelheim Investigational Site
- Wisconsin
  - Elkhorn, Wisconsin, United States
    - 1160.26.0072 Boehringer Ingelheim Investigational Site
  - Green Bay, Wisconsin, United States
    - 1160.26.0234 Boehringer Ingelheim Investigational Site
  - Madison, Wisconsin, United States
    - 1160.26.0099 Boehringer Ingelheim Investigational Site
  - Madison, Wisconsin, United States
    - 1160.26.0242 Boehringer Ingelheim Investigational Site
  - Marshfield, Wisconsin, United States
    - 1160.26.0359 Boehringer Ingelheim Investigational Site
  - Milwaukee, Wisconsin, United States
    - 1160.26.0461 Boehringer Ingelheim Investigational Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Genders Eligible for Study

All

Description

Inclusion criteria Patients with non-valvular atrial fibrillation (AF), at moderate to high risk of stroke, or systemic embolism with at least one additional risk factor (i.e. previous ischemic stroke, TIA, or systemic embolism, left ventricular dysfunction, age >=75 years, age >=65 with either diabetes mellitus, history of coronary artery disease or hypertension)

Exclusion criteria

Prosthetic heart valves requiring anticoagulation per se, or hemodynamically relevant valve disease that is expected to require surgical intervention during the course of the study
Severe, disabling stroke within the previous 6 months, or any stroke within the previous 14 days
Conditions associated with an increased risk of bleeding
Contraindication to warfarin treatment
Reversible causes of atrial fibrillation (e.g., cardiac surgery, pulmonary embolism, untreated hyperthyroidism).
Plan to perform a pulmonary vein ablation or surgery for cure of the AF
Severe renal impairment (estimated creatinine clearance <=30 mL/min)
Active infective endocarditis
Active liver disease
Women who are pregnant, lactating, or of childbearing potential who refuse to use a medically acceptable form of contraception throughout the study
Anaemia (haemoglobin <100g/L) or thrombocytopenia (platelet count <100 x 109/L)
Patients who have developed transaminase elevations upon exposure to ximelagatran
Patients who have received an investigational drug in the past 30 days or are participating in another drug study
Patients considered unreliable by the investigator concerning the requirements for follow-up during the study and/or compliance with study drug administration, has a life expectancy less than the expected duration of the trial due to concomitant disease, or has any condition which in the opinion of the investigator, would not allow safe participation in the study (e.g., drug addiction, alcohol abuse)
Any known hypersensitivity to galactose if the warfarin used contains galactose.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Primary Purpose: Prevention
Allocation: Randomized
Interventional Model: Parallel Assignment

Number of Arms

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Dabigatran dose 2 twice a day	Drug: Dabigatran dose 2 twice a day
Active Comparator: Warfarin once a day	Drug: warfarin once a day
Active Comparator: Dabigatran dose 1 twice a day	Drug: Dabigatran dose 1 twice daily

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Yearly Event Rate for Composite Endpoint of Stroke/SEE Time Frame: 36 months	Time to first occurrence of stroke or systemic embolic event. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25	36 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Yearly Event Rate for Composite Endpoint of Stroke/SEE/All Cause Death Time Frame: 36 months	Time to first occurrence of stroke, SEE or all cause death. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25	36 months
Yearly Event Rate: Composite of Stroke/SEE/PE/MI/Vascular Death Time Frame: 36 months	Time to first occurrence of stroke, systemic embolic event, pulmonary embolism, myocardial infarction including silent myocardial infarction or vascular death. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25	36 months
Bleeding Events (Major and Minor) Time Frame: 36 months	Yearly event rate of bleeds. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25 Major bleeds are adjudicated, whereas minor bleeds are investigator reported.	36 months
Clinical Relevant Abnormalities for Intracerebral Hemorrhage and Other Intracranial Hemorrhage (ICH) Time Frame: 36 months	Patients with clinical relevant abnormalities for intracerebral hemorrhage, other intracranial hemorrhage (ICH)	36 months
Abnormal Liver Function Test Time Frame: 36 months	Number of subjects with abnormal liver function test (LFT), i.e., ALT/AST>3xULN and total bilirubin > 2 x ULN	36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Boehringer Ingelheim

Collaborators

Uppsala University

Population Health Research Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Related Info

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2005

Primary Completion (Actual)

April 1, 2009

Study Registration Dates

First Submitted

December 6, 2005

First Submitted That Met QC Criteria

December 6, 2005

First Posted (Estimate)

December 7, 2005

Study Record Updates

Last Update Posted (Actual)

April 17, 2019

Last Update Submitted That Met QC Criteria

April 8, 2019

Last Verified

April 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

1160.26
2005-003894-26 (EudraCT Number: EudraCT)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

University Hospital, Ghent

Recruiting

Data Collection of Patients Admitted to the Stroke Unit (PRODA-STROKE)

Stroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke Hemorrhagic

Belgium
Moleac Pte Ltd.

Recruiting

MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits (MAESTOSO)

Stroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic

Singapore, Philippines
Moleac Pte Ltd.

Not yet recruiting

MLC1501 Study Assessing Efficacy in STROke Recovery (MAEStro)

Stroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
IRCCS San Camillo, Venezia, Italy

Recruiting

Efficacy of REMO Training for Hand Motor Recovery After Stroke (REMO)

Stroke | Stroke, Ischemic | Stroke Sequelae | Stroke Hemorrhagic

Italy
Vanderbilt University Medical Center
Patient-Centered Outcomes Research Institute; University of Alabama at Birmingham

Enrolling by invitation

Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care (C3FIT)

Stroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke Hemorrhagic

United States
University of Minnesota
American Occupational Therapy Foundation

Recruiting

duoABLE for People With Stroke and Their Caregivers

Stroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke Ischemic

United States
University of British Columbia
Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for...

Recruiting

Virtual Physical Activity Seated Exercise - Phase 2 (V-PASE)

Stroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic Stroke

Canada
University of Cincinnati
Medical University of South Carolina; University of California, Los Angeles; University...

Recruiting

Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials (VERIFY)

Stroke | Stroke, Ischemic | Stroke, Acute | Stroke Hemorrhagic

United States
University of Liege

Completed

Evaluation of Acute Post-thrombectomy Complications for Stroke (Stroke ICU)

Stroke, Acute | Stroke Hemorrhagic | Stroke, Complication

Belgium
Turkish Stroke Research and Clinical Trials Network
ElectroCore INC; Turkish Neurological Society

Completed

Non-invasive TRanscutaneous Cervical Vagus Nerve Stimulation as a Treatment for Acute Stroke; Safety and Feasibility Study (TR-VENUS)

Stroke | Stroke, Ischemic | Stroke, Acute | Stroke, Hemorrhagic

Turkey

Clinical Trials on Dabigatran dose 2

Boehringer Ingelheim

Completed

Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement

Thromboembolism | Arthroplasty, Replacement, Knee

United States, Canada, Mexico, United Kingdom
Boehringer Ingelheim

Completed

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

Atrial Fibrillation

United States, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Israel, Italy, Korea, Republic of, Malaysia, Netherlands, Norway, Phili... and more
Boehringer Ingelheim

Completed

Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects

Healthy
Boehringer Ingelheim

Completed

Pharmacokinetics, Safety and Pharmacodynamics After Multiple Oral Doses of Dabigatran Etexilate Capsule in Healthy Japanese and Caucasian Male Subjects

Healthy
Boehringer Ingelheim

Completed

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment

Renal Insufficiency
Boehringer Ingelheim

Terminated

Dabigatran Etexilate in Patients With Mechanical Heart Valves (RE-ALIGN)

Heart Valve Diseases

Belgium, Canada, Czech Republic, Denmark, France, Germany, Netherlands, Norway, Poland, Sweden
Boehringer Ingelheim

Terminated

Follow on Study From RE-ALIGN

Thromboembolism | Heart Valve Prosthesis

Belgium, Canada, Czech Republic, Denmark, France, Germany, Netherlands, Norway, Poland
Medy-Tox

Completed

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

Lateral Canthal Lines | Glabellar Lines

United States, Russian Federation, Germany, Canada, Belgium, United Kingdom
Ablynx

Completed

Caplacizumab Single and Multiple Dose Study in Healthy Japanese and White Subjects.

Healthy Volunteers

United States
Loyola University
National Cancer Institute (NCI)

Active, not recruiting

Transfer of Genetically Engineered Lymphocytes in Melanoma Patients

Melanoma

United States

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate

Study Overview

Status

Conditions

Intervention / Treatment

Study Type

Enrollment (Actual)

Phase

Contacts and Locations

Study Locations

Participation Criteria

Eligibility Criteria

Ages Eligible for Study

Accepts Healthy Volunteers

Genders Eligible for Study

Description

Study Plan

How is the study designed?

Design Details

Number of Arms

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure

Measure Description

Time Frame

Secondary Outcome Measures

Outcome Measure

Measure Description

Time Frame

Collaborators and Investigators

Sponsor

Collaborators

Publications and helpful links

General Publications

Helpful Links

Study record dates

Study Major Dates

Study Start (Actual)

Primary Completion (Actual)

Study Registration Dates

First Submitted

First Submitted That Met QC Criteria

First Posted (Estimate)

Study Record Updates

Last Update Posted (Actual)

Last Update Submitted That Met QC Criteria

Last Verified

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Clinical Trials on Stroke

Clinical Trials on Dabigatran dose 2

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations